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ABSTRACT 
Engineering Escherichia coli for the production of polyketide-based platform 
chemicals 
by 
John Park 
The current chemical industry produces a diverse array of industrial chemicals 
from a handful of highly reduced byproducts (termed "platform chemicals") derived from 
oil refining. However, petroleum is a non-renewable resource, and increases in its cost 
have created pressure to convert the chemical industry into one that is renewable to 
ensure its long-term viability. To complete this objective, one approach is the conversion 
of biomass to platform chemicals through fermentation by Escherichia coli. One such 
platform chemical is methyl ketone, which can be readily converted to dienes that can 
directly replace existing platform chemicals such as ethylene. To bestow non-native 
methyl ketone production capability to E. coli from glucose, the polyketide biosynthesis 
pathway was exploited in conjunction with grafting in a heterologous methyl ketone 
synthesis pathway found in wild tomato species Solanum habrochaites to produce the 
methyl ketones. Cultivation under microaerobic conditions improved titers and yields, 
and further engineering to knock out the native competitive pathways that become 
activated under microaerobic conditions led to significantly improved strains. The final 
strain, LJadheLJldhaLJptaLJpoxB [pTrcHis2A-shmks2-mksl], produced up to 450 mg/L of 
methyl ketones at 17 mg of methyl ketones produced per gram of glucose consumed 
under optimized operating conditions in minimal media supplemented with glucose. 
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1. INTRODUCTION 
Since the discovery of fire, humans have been harnessing bio-based products and 
inorganic materials as energy sources and feedstocks for the production of materials. 
However, starting with coal during the Industrial Revolution, society has increasingly 
depended on non-renewable fossil carbon for the manufacture of these materials. Over 
time, this dependence has expanded into other types of fossil carbon which have 
historically been inexpensive and abundant such as petroleum and natural gas. Currently, 
ninety percent of the world's commodity chemicals are derived from these fossil carbon 
sources, with only a small remainder derived from bio-renewable carbon sources. 
However, in the last 10 years, a number of developments have restored interest in using 
renewable sources of carbon. Primarily, rapid increases in the global demand for energy 
have dramatically raised the consumption rate and cost of fossil fuels, which has led to 
some concern over the remaining supply of fossil fuels and consequently the future of the 
chemical industry. These developments have spurred advancements in oil discovery and 
recovery efforts, which have been moderately successful in increasing the supply of oil 
albeit, in some cases, at the cost of negative environmental impacts. Spirited research into 
alternative energy sources such as solar, wind, and nuclear have yielded promising 
results, moving us closer and closer to a renewable society. However, the fact remains 
that these can only be short-term solutions for the chemical industry. In addition to fossil 
carbon being inherently non-renewable, the production of industrial chemicals relies on a 
carbon backbone, and thus it is imperative that a way is found for their production from a 
renewable carbon source. 
1 
The chemical· sector is the largest industrial consumer of energy products, 
consuming approximately 15 percent of the world's total delivered energy and making up 
29 percent of the world's industrial energy consumption in 2006 as shown in Figure 1 1• It 
is important to note that within the chemical sector, the majority of the energy consumed 
is used as feedstock for the production of industrial organic chemicals, as opposed to its 
traditional use as a fuel source. Though the rest of the world's energy is consumed 
through the transportation sector, the value of all chemicals derived from energy products 
is approximately equal to that of transportation fuels, illustrating the importance and large 
economic impact of the petrochemical industry. Indeed, the products derived from 
industrial chemicals have significantly impacted society through their myriad 
applications ranging from food additives to plastics. Additionally, these products see 
widespread use due to their low unit costs, made possible by highly optimized processing 
of hydrocarbons derived from fossil carbon. Understanding this tightly-knit association of 
the chemical industry with petroleum and gas is the first key step in assessing viable 
approaches to a sustainable solution for the chemical industry. 
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Figure l. World industrial sector energy consumption 
2 
The heavy dependence of the chemical industry on oil and natural gas is clear 
when one looks at its inception. The chemical industry as it is known today was formed 
around the need to use hydrocarbon by-products generated by the refining process of 
crude oil that were too volatile for use as transportation fuels. These undergo fluid 
catalytic cracking to form ethylene and propylene, which along with benzene are 
converted through various chemical processes such as oxidation, alkylation, and 
polymerization to a vast array of chemical products 2• 3• For example, Figure 2 shows a 
number of large-volume industrial chemicals that are derived from propylene and 
ethylene. 
Figure 2. Large-volume chemicals derived from two example platform chemicals 
(Source: Center for Biorenewable Chemicals (CBiRC), http://www.cbirc.iastate.edu/.) 
Over the past 80 years, improvements in feedstock conversion and downstream 
chemical processes have led to highly optimized utilization of oil and gas by-products in 
the industry. Central to this efficiency is the use of the aforementioned building blocks, 
known as platform chemicals, that are derived from these fossil carbon sources. This is 
best illustrated in Table 1, which lists the top 20 industrial chemicals used in the United 
3 
States 4• Platform chemicals are at or near the top of the list, confirming their significance 
in the industry. 
Table 1. List of the top 20 industrial chemicals used in the United States 
1 Ethylene 11 Ethylene oxide 
2 Propylene 12 [1-xylene 
3 Ethylene dichloride 13 Cumene 
4 Methanol 14 Ethylene glycol 
5 Vinyl chloride 15 Butadiene 
6 Benzene 16 Phenol 
7 Ethylbenzene 17 Acetic acid 
8 Styrene 18 Acrylonitrile 
9 Terephthalic acid 19 a-olefins 
10 Formaldehyde 20 Propylene oxide 
The reliance of the current chemical industry on fossil carbon-derived platform 
chemicals means it is vulnerable to the cost and supply of oil and natural gas. On top of 
the inherent price volatility of these resources, the average prices are forecasted to 
increase in the near future according to the most recent International Energy Outlook 
document published by the U.S. Department of Energy as shown in Figure 3. These two 
economic trends will negatively impact the growth and investment of the chemical 
industry 5. 
4 
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Figure 3. World oil prices in the 2008 and 2009 International Energy Outlook (lEO) reference cases 
(Source: Energy Information Administration (EIA), Annual Energy Outlook 2009, DOE/EIA-0383(2009) (Washington, DC, March 
2009), web site www.eia.doe.gov/oiaf/aeo.) · 
More importantly, however, is the dwindling supply of fossil carbon resources. 
Producing carbon-based chemicals from fossilized carbon is inherently non-sustainable, 
as it requires millions of years to form naturally, a rate which is far surpassed by the rate 
of its current consumption, which is predicted to continually rise as shown in Figure 4. 
Along with rising consumption, the majority of forecasts of world oil production predict 
the maximum to occur between 2010 and 2020, followed by a rapid decline through the 
following decades as shown in Figure 5. Eventually, the supply of fossil carbon will 
either be exhausted or prohibitively costly to acquire, so a long-term solution is required 
for the transformation of the current petroleum-based chemical industry to one that will 
be able to use a feedstock with a timescale of formation equal to that of its utilization. 
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Figure 4. World energy consumption by fuel type 
(Sources: 2006: Energy Information Administration (EIA), International Energy Annual2006 (June-December 2008), web site 
www.eia.doe.gov/iea. Projections: EIA, World Energy Projections Plus (2009). ) 
Biomass, with its short formation time, low cost, and ability to supply carbon, is 
currently the only option as a renewable feedstock for the chemical industry 6• The 
impetus to switch to this option is, as aforementioned, dependent on the remaining supply 
of fossil carbon. However, unlike its use as an energy source, which could be resolved 
through the use of alternative energy technologies such as solar, wind, and nuclear, the 
production of organic chemicals can only attain sustainability through the use of biomass, 
given the inherent need for a carbon backbone in industrial chemicals. 
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Figure 5. World oil production (crude oil and natural gas) along with various forecasting models 
using historical data between 1940 to 2006 from the Energy Information Administration (DOE) 
(source: Foucher, S. Production Forecasts and EIA Oil Production Numbers. http://www.theoi ldrum.com/story/2006/ ll / 13/225447/79) 
1.2. INTEGRATION OF A BIO-BASED CHEMICAL INDUSTRY WITHIN A BIO-
REFINERY FRAMEWORK 
In order to move the chemical industry toward biomass without significant costs, 
processes will need to be developed that will allow efficient conversion of feedstocks . 
Mirroring the petrochemical industry, which is highly integrated and productive, many 
believe a bio-based chemical industry will be successful if built upon a platform chemical 
approach 7• 8. Werpy and Peterson (2004), through a collection of expert opinion from 
industry, introduced a list of 12 potential biologically-derived platform chemicals as 
shown in Figure 6, which could be converted to a number of chemical products such as 
acrylic acid, 1,3-propanediol, acrylamide, and acrylonitrile. However, the proposed 
synthetic routes, either through a biological process or the chemical conversion of a 
biological precursor, are currently not economically viable due to their low effic iency, 
7 
- ---~-------------
but further research is warranted to improve these processes 6• Since the listed chemicals 
are able to be produced through the fermentation of sugars in biomass, one potential way 
to increase the viability of these processes is to co-locate them at a site which also 
produces biofuels, a concept which is called a bio-refmery 9• 
Ca c4 r HOC.A.._..-CO.H 0 • po OH SUccinic acid HO~QH 
Glycerol HO,c"""vCO,H 
c. Ft.rnarlc acid 3-Hydroxy-Dlaclds butyrolactone 
HO.A.._..-C02H OH ~H, 
3-Hydroxyproplonlc acid HO,C.-lyco,H HO~CO,H 
Malic acid • Aspartic acid 
Cs Cs 
OH OH OH OH OH OH 
HO•yco,H H~OH HO~OH HO,C~CO,H 
OH 0H OH 0H OH 
Itaconic acid Xylltol Sorbitol Glucaric acid 
HO,&CH, 
~H, Ho,c-()-'CO,H H02~C02H 
Levullnlc acid Glutamic acid 2,5-Furandlcarboxyllc acid 
Figure 6. A list of 12 potential bio-based platform chemicals as presented in Werpy and Peterson 
(2004) 8 
A bio-refinery is analogous to a crude oil refinery, wherein multiple fuel and 
platform chemicals are co-produced from a single feedstock at a single location. The 
difference lies in the feedstock that is utilized; in a traditional refmery, crude oil is the 
main feedstock, whereas in a bio-refmery, biomass is the main feedstock. By using both a 
portion of the feedstock as well as by-products from the production of biofuel, chemicals 
can be made to offset costs and maximize the value of the biomass feedstock. One current 
example of a bio-refmery is the com wet mill, which produces ethanol along with 
proteins, lactic acid, maltodextrins, and smaller specialty chemicals IO, II. The scheme for 
8 
this process is in Figure 7, which illustrates how one feedstock can lead to a diverse array 
of products. The co-production of chemicals and biofuels at a single site vastly increases 
the economic viability of the production of both biofuels and bio-based chemicals 
through integration of feedstock and by-product handling, economy of scale, internal 
management of energy requirements, and sharing of utilities 12• However, before such a 
concept can be implemented, the processes involved with the production of chemicals 
from both the biomass feedstock and biofuel waste streams need to be developed. 
Figure 7. Corn wet mill bio-refinery processes 
(source: Center for Transportation Ana lysis, Oak Ridge Nat ional Laboratory. 
http:/ /cta.ornl.gov/bedb/biofuels/ethanolffhe _Ethanol_ Production_ Process-Wet_ M i II ing-Figure.xls) 
1.3. FEASIBILITY OF REPLACING EXISTING PLATFORM CHEMICALS WITH 
BIO-BASED PLATFORM CHEMICALS 
Another challenge for the production of bio-based chemicals is their integration 
into the existing chemicals market. Current platform chemicals such as ethylene, due to 
being derived from hydrocarbon feedstocks, have a low oxygen-to-carbon ratio - that is, 
9 
the carbon is highly reduced. However, many proposed bio-based platform chemicals, 
such as those in Figure 6, are derived from the carbohydrate portion of biomass, resulting 
in high oxygen-to-carbon ratios. Direct replacement of currently-used platform chemicals 
will require the removal of oxygen, an energy-dependent process that will add to the cost 
of producing bio-based chemicals, which is already struggling to be economically viable. 
An alternative to direct replacement of platform chemicals is the functional 
replacement of existing petrochemicals. In order for this replacement to occur, the bio-
based chemical must have functional properties similar to or better than the chemical it is 
replacing. Some proposed functional replacements with bio-based chemicals include 
ethyl lactate for replacing hydrocarbon solvents, 2,5-furandicarboxylic acid for 
terephthalic acid (monomer in polyesters), and glucaric acid for adipic acid (monomer in 
nylons) 13• 14• This avenue of approach could yield additional benefits through 
improvements over existing chemicals, increased range of applications for certain 
chemical products, and the discovery of novel chemicals. However, in reality, fmding 
new areas of chemicals applications has become increasingly difficult 6• Consequently, 
functional replacements will most likely compete with existing chemical markets instead 
of creating a new market, as is the case with polylactic acid, a new bio-based polymer 
which has the features for replacing existing polymers but not enough to create a new 
market. In addition, there are high barriers to entry regarding the launch of a new 
industrial chemical, estimated to be US$1 billion covering both process and market 
development 15• 
The best approach for a successful implementation of an industrial chemical 
industry based on biomass would most likely target both direct and functional 
10 
replacement of existing industrial chemicals. The bio-based platform chemicals listed in 
Figure 6, even with the aforementioned disadvantages, could still be involved in this type 
of approach, assuming highly efficient processes can be developed for them. However, 
unlike ethylene, propylene, and benzene, the 12 bio-based platform chemicals are much 
less reduced and do not have an extensive array of derivatization processes, restricting 
their impact to a limited number of products. 
A more promising approach to bio-based chemicals is to move away from those 
that are carbohydrate-based to those that are polyketide/fatty acid-based. Chemicals 
resulting from this portion of biomass are composed of carbon that is in a more reduced 
form (lower oxygen-to-carbon ratio), making them better candidates for direct 
replacement since little to no energy will need to expended for their reduction. Secondly, 
the chemicals from polyketide/fatty acid synthesis (F AS) are produced from a single, 
cyclical metabolic pathway with the flexibility to generate various types and lengths of 
molecules that can carry an assortment of chemical functionalities in the form of 
controlled R -groups for the production of novel monomers. Lastly, fatty acid biosynthesis 
and its regulation have been studied extensively in Escherichia coli, providing key 
information needed for the rational design and engineering of the relevant metabolic 
pathways 16-18 • Thus, the polyketide/fatty acid biosynthesis provides an ideal framework 
for the production of a vast number of bio-based platform chemicals and subsequent 
manufacture of industrial chemical products. However, it is important to note that the 
biological end products derived from the F AS pathway, though they are highly reduced in 
nature, cannot directly replace existing platform chemicals as-is due to their remaining 
11 
carboxyl/carbonyl groups. To realize the production of bio-based industrial chemicals 
within the framework, they can act as close intermediate chemicals that can be readily 
converted through chemical catalysis into the desired platform chemical that can be 
integrated seamlessly into existing chemical industry infrastructure. Thus, a multi-
disciplinary, collaborative research effort is required. Currently, this is spearheaded 
through the NSF Engineering Research Center for Biorenewable Chemicals (CBiRC), 
which has assembled from among eight U.S. and four foreign institutions a group of over 
30 faculty knowledgeable in fields ranging from microbiology to chemical catalysis. 
Central to the overall research is the aforementioned idea of the optimized coupling of 
biocatalysis (use of an organism's metabolism for the production of a desired product) 
and chemical catalysis to connect the intermediate to the final platform chemical, which 
is shown in Figure 8. This structure is analogous to that of the petrochemical industry, 
where biocatalysis takes the place of feedstock conversion (crude oil refining), and 
chemical catalysis and polymerization constitute the derivatization processes. 
12 
Fermentalio11 
Figure 8. CBiRC's engineering platform and various testbeds 
(source: NSF Engineering Research Center for Biorenewable Chemicals (CBiRC), http://www.cbirc.iastate.edu/researchdetails.asp) 
The first row of compounds in Figure 8 are those that are known to be produced 
biologically in various organisms. The second row shows the corresponding fmal 
platform chemicals that result from modifications through chemical catalysis of the 
aforementioned compounds/intermediates. The third row shows the commodity 
chemicals that can be produced from the platform chemicals of the second row. In the 
proposed research, the focus will be on optimizing the first step of the process - the 
bioproduction of the intermediate chemicals in the first row. 
1.5. THE GENERAL APPROACH AND TARGETS FOR PRODUCTION 
In the area of biocatalysis, the first step is to identify and/or develop enzymes that 
will connect intermediates from the F AS pathway to the intermediate chemicals. This can 
be achieved through two strategies: (1) the structure-function relationship knowledge 
base can be used to develop new functionalities in existing biocatalysts, and (2) genomics 
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and metabolomics data from a wide variety of organisms can be used to identify novel 
enzymes that have been shown to produce these compounds from the F AS pathway. 
Once these enzymes are obtained, they will be introduced into Escherichia coli, a host 
organism that is ideal due to extensive knowledge of its metabolism, genetics, behavior, 
and the availability of a wide array of tools for its genetic modification. The next step is 
the development of design rules to systematically construct and optimize these strains for 
converting renewable feedstocks (such as glucose) into the desired products (second row, 
Figure 8). A systems approach will help guide the design of efficient microbial strains. 
A primary long-term goal currently is the synthesis of compounds with 3-ene-2-
one functionality, as shown in Figure 9. 
R 
3 1 
Figure 9. The long-term target for the biological precursor to the ideal platform chemical 
This type of compound opens the door to a variety of possible platform chemicals 
through derivatization processes (chemical catalysis). For example: the carbon-to-carbon 
double bond can be selectively hydrogenated to form ketones; the carbonyl group can be 
hydrogenated to form unsaturated alcohols; the unsaturated alcohol can be dehydrated to 
form dienes. Dienes are an especially interesting product, as they can be used directly in 
the polymer industry and can be readily converted to olefms and diols, providing a great 
platform for a wide variety of chemical applications. 
The short-term goal is a small step back from molecules with 3-ene-2-one 
functionality, and instead focuses on molecules with 2-one functionality (methyl 
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ketones). Methyl ketones can be used as platform chemicals themselves, and can also be 
readily converted to dienes which could directly replace existing platform chemicals such 
as ethylene and propylene.19 Recently, two classes of methyl ketone synthases (MKS 1 
and MKS2) were isolated and characterized from wild and cultivated tomato as the 
enzymes responsible for generating methyl ketones from the F AS pathway 20• 21 . The 
second class of methyl ketone synthases, MKS2's, are thought to catalyze the first step of 
methyl ketone synthesis, which is the hydrolysis of the thioester bond of the 3-ketoacyl 
ACP intermediate in the F AS pathway, resulting in a 3-ketoacid. The first class, MKS 1's, 
are thought to catalyze the next step, which is the decarboxylation of the 3-ketoacid into a 
methyl ketone. 
Though it is not approached in the experimental portion of this study, another 
long-term goal is the bioproduction of ring pyrones. These can be converted through 
chemical catalysis into platform chemicals with ring structures, which have a wide 
variety of applications such as in the production of polystyrenes and nylons. 19 One 
pyrone of particular interest is triacetic acid lactone, or TAL (Figure 1 0). TAL can serve 
as a platform chemical by being readily converted through chemical synthesis to: (1) 
sorbic acid, a food and feed preservative, (2) 1,3-pentadiene, for resins, plastics, and 
adhesives, and (3) 3-pentene-2-one, a useful chemical in a variety of chemical syntheses. 
Though it is currently made industrially in five chemical steps starting with the pyrolysis 
of acetic acid 22• 23 , there have been discovered three different biosynthetic routes to it 
from fatty acid synthesis intermediates.24 
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Figure 10. Triacetic acid lactone 
While the discovery of new pathways for the synthesis of these target molecules 
is a critical first step, significant effort needs to be spent on incorporating and developing 
efficient microbial strains that will make producing these target molecules and the whole 
process economically viable. The specific objectives include: integration of new 
pathways into stable E. coli chassis, efficient pathway design to allow proper balance 
between cell growth and product formation, balanced carbon and co-factor flow, 
maintenance of robust performance even at high product titers, and eventual scale-up 
with industrial input. 
We hypothesized the successful production of methyl ketones through expression 
of heterologous proteins known to produce methyl ketones from fatty acid synthesis 
intermediates within wild tomato (Solanum habrochaites). Furthermore, we hypothesized 
increased titers and yields from growth conditions leaning microaerobic conditions, as 
this will increase the availability of reducing equivalents for use in fatty acid synthesis, 
the diversion of acetyl-CoA towards fatty acid synthesis through inactivation of the TCA 
cycle, while at the same time providing a minimal amount of oxygen to improve growth 
characteristics and to act as the external electron acceptor to complete the redox-balance 
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from glucose to methyl ketone. Finally, we hypothesized further increased titers and 
yields from inactivation of the mixed acid fermentative pathways that become active in 
microaerobic conditions, which not only compete for carbon with the fatty acid synthesis 
cycle but consume reducing equivalents required for the fatty acid synthesis reactions. 
The aim of this study is to enable the ability of E. coli to produce methyl ketones 
from glucose and apply metabolic engineering to increase the production efficiency. Prior 
studies on the production of platform chemicals have involved the over-production of 
relatively oxidized compounds from the carbohydrate portion of biomass, but no studies 
exist in the current literature concerned with engineering E. coli for the production of 
platform chemicals such as methyl ketones derived from intermediates in the polyketide 
portion of biomass. This study focuses on how heterologous proteins can be used in E. 
coli to synthesize platform chemicals such as methyl ketones and how its production can 
be optimized through balancing cell growth, carbon flow, and co-factor availability by 
consideration of aerobicity during growth and strategic pathway knockouts. 
The specific objectives are described below and will be discussed in the body of 
this work: 
• Design of pathways leading to methyl ketones: Initially, a systematic review of 
existing knowledge will be done regarding the biochemical reactions involved 
with the conversion of glucose to methyl ketones. This will lead to the 
identification of enzymes involved in the synthesis of methyl ketones (to be later 
introduced in various host strains), calculation of the overall balance from glucose 
to methyl ketones, and preliminary strategies for the optimization of the 
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recombinant pathways. Balance calculations will guide co-factor optimizations of 
producing strains. All of the above will provide the genetic design rules for 
metabolic engineering in order to achieve the overall objectives. 
• Identification of products: SDS-PAGE analysis of whole cell extract will be used 
to confirm expression of methyl ketone synthases on the protein level, and methyl 
ketone production will be confirmed by GC-MS on the product level. Major and 
minor products will be identified to guide quantification of total methyl ketone 
production through GC-FID. 
• Strain characterization and establishment of optimal operating conditions: 
Production strains will be assessed under a variety of operating conditions. 
External factors such as type of growth media and aerobicity will be varied. 
Internally, expression levels of methyl ketone synthases will be varied to find the 
proper balance between cell growth and product formation. Performance will be 
evaluated using fermentation profiling using HPLC and measurement of product 
formation through GC-FID. Metrics to be optimized are primarily titer and yield. 
• Strain improvement through genetic modification : Following establishment of 
optimal operating conditions, potential metabolic engineering targets will be 
identified and executed. Effect of modifications will be evaluated using 
fermentation profiling using HPLC and measurement of product formation 
through GC-FID. 
The proposed work will result in strains optimized for the production of the first 
polyketide/fatty acid-based platform chemicals, as well as increased understanding of the 
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pathways responsible for generating the intermediates to platform chemicals. In addition, 
this knowledge will greatly aid future research endeavors targeting other polyketide/fatty 
acid-based chemicals, bringing society closer and closer to a sustainable future. 
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3. LITERA TtJRE REVIE\V 
The goal of this literature review is to cull: (i) all existing knowledge regarding 
the techniques for the metabolic engineering of E. coli, paying particular attention to the 
methodologies employed in the past for the production of novel compounds, and (ii) all 
knowledge on the protein, genetic, and biochemical levels pertaining to the synthesis of 
methyl ketones. Review of these two areas will lead to an initial set of design rules as 
well as a logical approach through which to execute on those. 
Metabolic networks in cells are comprised of thousands of regulated and coupled 
chemical reactions that are driven by enzymes and membrane transport systems. 
Unfortunately, these networks as they have become evolved in nature are rarely 
optimized for practical applications. However, rapid improvements in molecular biology 
have given rise to technology that enables the genetic modification of cells to produce 
strains that have desirable properties. 
Metabolic engineering is the application of molecular biology for the optimization 
of a specific network of biochemical reactions within an organism towards a specific 
goal. This goal is either the formation of desired products such as antibiotics, polymers, 
industrial chemicals, or the modification of cellular properties such as through the 
extension of metabolic capabilities. Inherent to these objectives, in the case of production 
of a metabolite, is the optimization of yield, productivity, and titers. In order to achieve 
these goals, several approaches (in terms of genetic modifications) have been used. For 
the increased production of an existing metabolite, typically the amplification of a gene 
or set of genes is performed to increase the flux along the biochemical reactions between 
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the substrate and the final product. Another method to enhance product formation is the 
removal or inhibition of an enzyme to knock out a competing pathway or one that leads 
to a toxic byproduct. For the production of novel compounds that are not normally 
produced by the cell, heterologous enzymes can be expressed to build the non-native 
pathways that result in the desired product. This strategy can also be used to extend 
substrate range or confer the ability to degrade inhibitory products, such as in the case of 
bioremediation. A combination of all these approaches may be needed to achieve the 
goal. 
In order to apply these approaches in a rational and systematic manner, it is 
important to understand the properties of the pathway of interest from substrate to 
product, specifically the metabolic and information fluxes as well as their control. The 
use of analytical methods to reveal the underlying mechanisms of metabolic networks in 
combination with molecular biology techniques is what differentiates metabolic 
engineering from previous strain improvement efforts. Several techniques are used for 
this: (1) rigorous physiological studies, (2) metabolic flux analysis (MFA), (3) metabolic 
control analysis (MCA), (4) thermodynamics of the pathways, and (5) kinetic modeling. 
These techniques are used in metabolic engineering in order to determine the targets for 
modification as well as to correctly assess the consequences of a previous round of 
genetic modifications. In this study, due to the unknown regulatory patterns of fatty acid 
synthesis (incomplete knowledge), the lack of literature concerning MCA and MFA of 
the fatty acid synthesis pathway, these techniques were not used for rational modification 
in this study. In addition, the metabolic engineering was conducted was primarily through 
pathway deletions and the organization of the pathways were such that it did not 
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necessitate the need for MCA or MFA. Thus, the primary rationale technique for strain 
improvement was through analysis of the physiological studies. 
3.1.1. Physiological studies 
The combination of genetic work and classic cultivation studies are important for 
identifying unknown regulatory patterns and regulatory compounds. In addition, 
physiological studies allow the observation of the effects of genetic manipulations on 
growth and un-related systems. Normally, negative effects on growth can be attributed to 
increased metabolic burden on the cell by the modifications, but negative effects on un-
related pathways are harder to anticipate. For example, one study amplified 
phosphenolpyruvate-forming enzymes and observed inhibition of heat-shock enzymes 
and nitrogen regulation 25 • Another study involved the use of continuous cultures to 
ascertain the regulatory aspect of an oft-used promoter (TAKA) of Aspergillus oryzae, 
showing both glucose repression and maltose induction 26• 27• 
Prior engineering strategies for over-production of fatty acids have also been 
exclusively assessed through physiological studies in a relatively qualitative manner. 
Acetyl-CoA carboxylase, popularly over-expressed in studies where overproduction of 
fatty acids is the objective, was first over-expressed based on the belief that it was 
postulated to be the limiting step in fatty acid synthesis. 17 Only afterwards, after the effect 
of over-expression was confirmed to increase fatty acid production, was it established to 
be true. This type of rationale is in stark contrast to rationale applied to fmding the 
appropriate targets for increasing glycolytic flux, which has been done in a more 
quantitative manner through MFA and MCA due to the knowledge of the kinetics of each 
enzyme along the pathway and large quantities of data from isotope labeling studies.28 
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The lack of data for fatty acid biosynthesis may be due to historically low interest in 
overproducing fatty acids. However, there has been largely increased interest in this topic 
in recent years 6• 16• 17• 29-32 hi h 1 d t · h · · , w c may ea o more ngorous c aractenzation of the fatty 
acid pathway in E. coli in the near future and a more quantitative basis upon which to 
rationalize further modifications. 
3.1.2. Biosynthesis of industrial chemicals 
Long before the earliest written records, mankind has employed micro-organisms 
for the production of useful compounds from raw materials; for example, in the making 
of beverages such as beer and wine, which employs yeast to convert sugars (from grains 
in beer, from grapes in wine) to alcohols, and in the making of bread, which employs 
yeast for leavening. However, actual knowledge of the metabolic processes involved in 
the production of alcohols and organic acids is fairly recent, with reports in the literature 
first appearing in the early 191h century. Lactic acid is speculated to be the first chemical 
to be purposefully produced on an industrial scale through fermentation 33• In 1916, 
Chaim Weizmann patented the famous acetone-butanol-ethanol (ABE) fermentation 
process, which uses the fermentative metabolism of bacteria from the Clostridium Family 
to produce acetone, n-butanol, and ethanol from starch. This process played a vital role 
during World Wars I and II, as acetone was a key raw material in the manufacture of 
explosives. However, during the 1950s, the chemical synthesis of acetone from petroleum 
became a much cheaper alternative due to the sharp decline in the price of petroleum, and 
as of today there are no industrial plants running the ABE process. 
On the other hand, scientific breakthroughs were being made in the field of 
molecular biology. The landmark discovery of the structure of DNA in 1953 by Watson 
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and Crick, followed by the development of recombinant DNA techniques by Cohen and 
Boyer in 1973, opened the door to intentional and purposeful genetic modifications, also 
known as genetic engineering 34' 35 • With this new tool, it was now possible to improve 
strains for the production of desired compounds and even introduce foreign DNA into 
them for the production of novel compounds. 
Since the advent of genetic engineering, there has been increasing interest in 
engineering organisms for a multitude of applications, a significant one being the 
production of industrial chemicals. Petroleum-based conversion processes for the 
production of commodity organic chemicals are still highly efficient, being able to 
produce vast quantities of chemicals for relatively low cost due to economies of scale, 
flexibility, well-established nature, and current low price of oil. This economic efficiency 
creates a significant barrier to new production routes such as bioconversion. However, 
bio-production of organic chemicals comes with several advantages over petroleum-
based production. Specifically, the ability to use biomass (plentiful lignocelluloses, 
agricultural products, wastes) allows for a sustainable way to produce chemicals, as 
opposed to using petroleum, which is established as a non-renewable resource. In 
addition, the environmental effects of bioconversion may be relatively mild. The use of 
biomass as a feedstock would reduce the net carbon dioxide production (as biomass 
consumes carbon dioxide), production of greenhouse gases during the bioconversion 
could be reduced if addressed correctly, wastes could be used as feedstock, and 
byproducts of bioconversion are typically benign. Unfavorable economics, the primary 
barrier for establishing a bio-based chemicals industry, can be overcome through the 
increased conversion efficiency attained through genetic/metabolic engineering as well as 
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the expected increases in the oil-to-biomass cost ratio. In a recent report on biomass 
technologies, the U.S. Department of Energy envisioned that by 2030, at least 25% of the 
raw materials for chemicals will come from renewable sources such as biomass 36• 
There are three general bioconversion routes to organic chemicals: ( 1) the 
microbial fermentation of carbohydrates, (2) one-step enzymatic or microbial conversion 
of intermediates, and (3) enzymatic or microbial conversion followed by conventional 
catalytic conversion. The resultant biochemicals can enter the existing chemicals market 
through direct or indirect substitution. Direct substitution involves the production of an 
existing commodity chemical through a different, bio-based route; for example, as in the 
production of ethylene from ethanol. The advantage of direct substitution is that there is 
no need to develop a new market for the chemical since it already has established its 
utility. However, since new production routes for directly substituted chemicals competes 
with any pre-existent market share for that particular chemical, it must have an economic 
advantage over existing production routes. A review of the bioproduction of organic 
chemicals listed several candidates for direct substitution, which include acetaldehyde, 
acetic acid, acetone, acrylic acid, adipic acid, 1 ,3-butadiene, n-butanol, ethanol, ethyl 
acetate, ethylene, glycerol, isopropanol, maleic anhydride, methanol, methyl ethyl ketone, 
phenol, and propylene. 37 
In indirect substitution, a new chemical is produced that has a similar application 
to an existing chemical. In some cases, the new chemical may be better than the currently 
used chemical, in which case the current chemical is displaced. An advantage of indirect 
substitution is that it does not involve direct competition with existing chemicals, and 
thus bio-products have a higher chance at entering the market through this route. The 
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inherent disadvantage with this route is that new markets need to be established for the 
new chemical, and extensive product-development research may be required. An example 
of bioproducts that have entered through this route successfully are lactic acid 
copolymers such as polyhydroxybutyrate. The polymer sector of the organic chemicals 
industry is by far the largest in terms of annual production, and thus represents a 
significant market opportunity for potential bioproducts. 19 One example of an industrially 
produced bioproduct in this sector is polylactic acid polymer, produced by Cargill Dow 
LLC. PLA is considered to be a good alternative to petroleum-based plastics as there are 
several superior qualities to it such as biodegradability, biocompatibility, compostability, 
and low toxicity to humans over PET and other nylon-based plastics 38• The first step is 
the microbial fermentation of bacteria to produce lactic acid from biomass sugars, which 
is then converted to a ring (lactide) and polymerized via chemical synthesis. Cargill Dow 
currently relies on com grain as a source of glucose for PLA production, but research is 
on-going to develop fermentative organisms that allow a wider substrate range (e.g. the 
ability to convert pentose sugars) as well as a direct method to produce polylactide within 
the organism. Lactic acid itself is an important product of industrial importance, and thus 
various approaches have been attempted to improve its production within various 
organisms. Lactic acid bacteria, yeast, and fungal systems have been engineered to 
enhance lactic acid production. E. coli has also been metabolically engineered to enhance 
production of lactic acid from glucose, with most attempts involving the use of 
heterologous expression of lactic acid dehydrogenases in various expression systems 
coupled with the deletion of competing pathways, but in general the titers granted by 
these approaches are not competitive with lactic acid bacteria. 39 
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Succinnic acid is another bio-product that has been of great interest in the past 
five to ten years. The value of succinic acid lies in the fact that many high-value 
derivatives can be easily attained through chemical synthesis.19 Succinic acid is a major 
fermentative product of several bacteria including the obligate anaerobe 
Anaerobiospirillum succiniciproducens and facultative anaerobes belonging to the family 
Pasteurellaceae, such as Actinobacillus succinogenes and Mannheimia 
succiniciproducens.40 E. coli is also known to produce succinic acid, but only as a minor 
fermentation product, with wild-type E. coli preferring the other fermentative products 
such as acetic acid, formic acid, lactic acid, and ethanol to retain its redox balance, 
necessitating the need to redirect metabolic fluxes for increased succinic acid production 
as well as reducing the formation of other metabolites. To this end, ldhA and pjl double 
mutants have been engineered to block formation of lactic, acetic, and formic acids.41 
Unfortunately, cell growth was relatively slow, the authors concluding that this was due 
to the inactivation of enzymes related to pyruvate dissimilation. Further enhancement has 
been attained by amplification of carbon-dioxide fixing anaplerotic pathways, catalyzed 
by phosphoenolpyruvate carboxylase42' 43, malic enzyme, and pyruvate carboxylase44• 
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Since the goal of the work is to engineer E. coli for the production of methyl 
ketones, the first step is to explore the current knowledge of the pathways and enzymes 
responsible for their production in order to identify potential enzymes for introduction 
into the E. coli chassis. The pathway information will provide the way to connect a native 
metabolite in E. coli to methyl ketones, and any related enzyme sequence information 
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will provide the starting point in the genetic engineering required to introduce those 
necessary biochemical reactions in E. coli. 
Aliphatic methyl ketones are a class of organic chemicals whose natural origin 
has been studied and fmnly established over many years. The occurrence of methyl 
ketones in nature was first reported in 1858 when Williams discovered 2-undecanone as 
the primary constituent of oil from Ruta graveolens, a plant species 45 . Later, 2-
undecanone was also found to be present in other essential oils of plants 46. Afterward, 
many reports confirmed plants as producers of methyl ketones, with 2-nonanone, 2-
undecanone, and 2-tridecanone found in various quantities in a great many plant and seed 
oils 4749 . In some cases, their associated secondary alcohols (2-nonanol, 2-undecanol, 2-
tridecanol) occur together, and are thought to be the reduced equivalents of their 
corresponding methyl ketones 50 . 
However, plants are not the only producers of methyl ketones. They were also 
found to be in cheeses, milk, and butter by food scientists whose primary interests were 
to identify the source of volatile flavors 51• In fact, methyl ketones are ubiquitous 
compounds known to be produced by almost all walks of life, with at least one example 
in five of the six kingdoms of life (Animalia, Plantae, Fungi, Archaea, and Bacteria). This 
section aims to present current knowledge of the pathways, enzymes, and other relevant 
information pertaining to the production of methyl ketones in nature. 
3.2.1. Overview of the main pathways to methyl ketones 
There are two main pathways through which methyl ketones are synthesized. One 
pathway involves an intermediate from the fatty acid synthesis cycle (Figure 11), 3-
ketoacyl-ACP, which undergoes hydrolysis of the thioester bond catalyzed by a 
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thioesterase to form 3-ketoacid, which is subsequently irreversibly decarboxylated by a 
beta-decarboxylase to produce an odd-numbered methyl ketone (the intermediates of the 
fatty acid synthesis cycle are even-numbered). This is what is known to occur in plants 20 . 
The other pathway, which occurs mainly in bacteria and fungi , involves 3-ketoacyl-CoA, 
an intermediate from fatty acid degradation (Figure 12), producing methyl ketone via a 
similar thioesterase and beta-decarboxylase. 
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Figure 11. Methyl ketone synthesis from the fatty acid biosynthesis pathway 
Acyl-GoA 
Enoyl.CoA-
Hyoratase 
Beta Oxidation Pathway 
Methyl Ketone Formation 
FAD FAOH2 
~ 
Acyi-CoA-
Oehydrogenasa 
QH 0 
R~/CoA s 
L -3-Hydroxyacyi-CoA 
trans-u2-Enoyi-CoA 
NAOH 
NAO' + H" 
~ 
Hydroxyacy1.CoA-
Oehydrogenase 
3-Ketoacyi-CoA 
Acyi.COA Acetyi.COA 
Thloesterase 
0 
R~ 
Decarboxylase 
Metnyl Ketone 3-Ketoacld (beta ketoacid) 
Figure 12. Methyl ketone synthesis from the fatty acid degradation pathway 
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As is evident from the figures and pathway description, the methyl ketone 
precursors of both pathways differ only in their acyl group carrier. Another similarity is 
that both involve cleavage of the thioester bond and beta-decarboxylation. 
Indeed, there are at least three other ways bacteria produce methyl ketones not 
involved in either the production or degradation of fatty acids. Similar to the pathways 
mentioned earlier, one way is by decarboxylation of beta-ketoacids that are not the result 
of thioesterases. Many Clostridia species and some Pseudomonas produce ketones 
through beta-decarboxylation, most notably acetone from acetoacetate 52-54 . Another way 
bacteria produce methyl ketones is by oxidation of secondary alcohols 55 . Alkane 
degradation pathways in some bacteria also produce methyl ketones as intermediates in 
the pathway by converting alkanes into secondary alcohols via monooxygenase and 
subsequent oxidation by secondary alcohol dehydrogenase. Though five pathways to 
methyl ketones have been mentioned, there are only three types of immediate precursors 
to methyl ketones, which are shown in Figure 13. Specific details regarding these 
pathways and responsible enzymes will be found in the following sections. 
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Figure 13. Main precursors and reactions for producing methyl ketones. 
13.2.2. Methyl ketones in Plantae 
Many plants produce volatile essential oils synthesized and secreted by special 
glandular hairs on their leaves and stems called "trichomes". Many of the constituents of 
these oils are used by the plants to help ward off detrimental pests and contain methyl 
ketones of various lengths. In particular, medium-length methyl ketones such as 2-
undecanone are very effective at warding off insects and are found to be produced by 
many species in the plant kingdom 56• 57 Among these, one of the most prominent 
sources of methyl ketones are the glandular trichomes of the wild tomato species 
Solanum habrochaites 57 . As this species is by far the most well-studied regarding 
synthesis of methyl ketones (in fact, no other study exists on the subject of the 
identification of key enzymes in methyl ketone synthesis), this section will primarily 
focus on knowledge so far regarding this species. 
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In 2005, an enzyme expressed inS. habrochaites (accession PI126449) leading to 
the synthesis of methyl ketones was isolated and characterized for the first time 20 . This 
was done through a comparison of the gland EST databases between an accession of S. 
habrochaites (PI126449) that was a known producer of methyl ketones, and an accession 
(LA1777) that does not produce methyl ketones. An EST is an "Expressed Sequence 
Tag", a short sub-sequence of a eDNA sequence used for the identification of gene 
transcripts. Thus, through this comparison, a eDNA was identified that was abundant in 
PI126449 but rare in LA1777, and the enzyme encoded by the eDNA was designated 
Methyl Ketone Synthase 1 (MKS1). Further analysis showed the sequence to be similar 
to plant thioesterases (Figure 14 ), and levels of the MKS 1 transcript, protein, and 
enzymatic activity in a variety of accessions and plant organs correlated with the amount 
of methyl ketones present, implicating MKS 1 as a key enzyme in methyl ketone 
synthesis. The MKS 1 protein was then expressed in E. coli and purified from whole cell 
extract to catalyze in vitro reactions using C1 2, C14, and C, 6 3-ketoacyl-ACP substrates, 
which led to the production of c,,, C13, and C, 5 methyl ketones respectively, suggesting 
that MKS 1 can act as both a thioesterase and a decarboxylase, though the turnover rate 
was low. Sequence similarity showed that MKS 1 is a member of the large alpha/beta-
hydrolase-fold superfamily of esterases 58 . In this particular study, in vivo methyl ketone 
production in their recombinant E. coli strain was not measured, possibly due to the 
lower-than-detectable amounts of methyl ketones produced by their recombinant strain, 
or the lack of a method to extract methyl ketones from E. coli at the time. 
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(LeMJE refers to methyl jasmonate esterase from L. esculentum, and PNAE referes to polyneuridine aldehyde esterase from R. 
serpentina). 
In 2009, the same group published another study identifying two additional 
methyl ketone synthases, designated SHMKS2 and SLMKS2, from second-generation 
interspecific populations of S. habrochaites (wild tomato) and S. lycopersicum (cultivated 
tomato) respectively that were observed to have high methyl ketone content in their 
trichomes. Crossing the wild tomato species which can produce methyl ketones with the 
cultivated tomato species which cannot, allowed a segregation analysis that concluded a 
multiple quantitative trait loci requirement for the production of methyl ketones. In 
addition, five plants with high levels of 2-tridecanone production and five plants with no 
detectable levels of 2-tridecanone (all from the F2 generation) were chosen for a 
transcriptome analysis, where the RNA from the trichomes was extracted, reverse 
transcribed, labeled, then hybridized to a microarray containing tomato genes. Table 2 
shows the significant differentially expressed genes between the two bulks. One gene that 
was especially over-expressed (337-fold more) in the methyl ketone producing F2 plants 
was designated SHMKS2, and a similar transcript derived from the cultivated tomato 
species was 7.5-fold more highly expressed in the non-producing plants and designated 
SLMKS2. 
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Table 2. Transcr iptome analysis of genes that were differentially expressed in producing- and non-
producing- interspecific F2 strains 21• 
0 167657 
Al779239 
AF230371 
81925004 
81931228 
AW616884 
0 169296 
08719610 
0 168712 
ON169129 
AW039905 
Al777019 
AW615872 
BF097749 
8W688217 
8tv\412813 
o, 170232 
0 171038 
08683900 
BG131749 
Al772024 
08722221 
0 168641 
E$893822 
BG643000 
8W690350 
AW034502 
8G1lJ7766 
81928231 
81932160 
8G128416 
AW624755 
E$896328 
BE434841 
Annotation 
A protein related to a Pseudomonas thioesterase (Sh allele) 
rR A-1 6S ribosomal R A 
Allene oxide synthase 
Plasma membrane intrinsic protein 
Unknown 
Oehydrodolichyl diphosphate synthase 
0 A repair protein RA023 
Calcium-binding EF hand family protein 
Rubisco small subunit 1A 
Major latex protein-related (Sh allele) 
Peroxisomal protein involved in the activation of fatty acids 
Unknown 
Glycosyl transferase family 14 protein 
Mitochondrial 265 ribosomal Ri A protein 
Unknown 
Methyltran fera family 2 protein 
Protein kinase 
Casein kinase 1 protein family 
X-Pro dipeptidase 
A protein related to a Pseudomonas thioesterase ($1 allele) 
Unknown 
Unknown 
PSII oxygen-evolving complex 23 
Cell wall protein precursor 
Phospholipase A2{3 
GRAM domain-containing proteirv'abscisic acid-r ponsive 
protein-related 
Cytochrome P450, putative 
Aldolketo-reductase family protein 
AD-dependent epimerase/dehydratase family protein 
UDP-glucoronosyi/UDP-glucosyl transferase family protein 
Unknown 
,\-1ajor latex protein-related 
Chaperonin 
3-Ketoacyi-ACP ynthetase 2 nuclear gene 
+336.6 
+62.6 
+46.7 
+39 
+27.3 
+24.1 
+18.3 
+15.5 
+14.7 
+12.9 
+11 .8 
+11.2 
+ 11.1 
+9.2 
+9.1 
+8.8 
+8.4 
+7.2 
-7.1 
-7.5 
-7.6 
- 7.7 
-7.8 
-7.9 
-8.0 
-8.3 
-8.9 
-9.5 
-10.1 
-10.6 
-10.9 
- 11.9 
-12.5 
-15.2 
•corresponding GenBank accession numbers with the highest similarity are shown. "Ratio depicts 
the difference in average ratios oi high-MK over low-MK bulks in~ ur hybridizations for all of the probes 
that represent the same sequen e . 
The MKS2 protein is approximately 50-70% identical to vanous plant proteins 
whose functions are unproven, encoded by genes in the Arabidopsis thaliana and Oryza 
sativa genomes, and by ESTs found from the angiosperm family and white spruce Picea 
glauca. The sequence similarity has implied that the MKS2 protein is part of the 4-
hydroxybenzoyl-CoA thioesterase subfamily of hot-dog fold enzymes 59 . The protein 
sequence alignment of SLMKS2 and SHMKS2 to related plant proteins is shown m 
Figure 15. 
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BlGD249868 
GmAW394535 
SlMKS2 
ShMKS2 
PiAAS90598 
PqEX4127JJ 
VvCA042155 
ChDT554179 
Atri'OH0753 
A'flG68260.l 
AT1G68280.1 
1\TlG35290.1 
ATlG35250.l 
OSCA£01692 
SsOfrNACT 
Ps48BT 
BlGD249868 
CmAW3945JS 
Sl»KS2 
ShJ.lKS2 
PiAAS90598 
PgEX412733 
VvCA042155 
GhDT554179 
AtrF0440?53 
ATlG68260.l 
AT1G6B280.1 
AT1G35290.l 
A'l'lGJ5250. 1 
OsCAE01692 
SsDHNACT 
Ps4HB'l' 
HlG0249868 
GmAW394535 
SlMKS2 
ShHKS2 
PiAAS90598 
P'iJEX412733 
VvCA042155 
ChDT554179 
AtrF0440753 
AT1G68260.1 
Al'lG682 80. 1 
ATlG35290 . 1 
AT1G35250.1 
OsCAE01692 
SsDffNACT 
Ps411BT 
RlG0249868 
GmAW394535 
SlMKS2 
ShJ.IKS2 
PiMS90598 
PqEX412733 
VVCA042155 
GhDT554 179 
AtrFD440753 
AT1G68260.1 
AT1G68280.1 
AT1G35290 . l 
AT1GJ5250.1 
OsCAB01692 
Ss0Hl!AC1' 
Ps4HBT 
-------MLQTFSPSYKPLHLPISSLSLSSFSSSSASSVAFPVTRLLIPPRLRVLPNPRR 
------------------MSLPSPLYLNTTSFRLTRQSPFPFPRRRFNPPAFRSVSPLSS 
MATAMGAISGGISVGVNAR'fPHVQCSSf'IQNPTKKLSRALAl"PS.LR.l'ASC!'Il'VFRRALPP 
l -------MLQALLSPTHMAVPASRAHTRGLRLYRPPLLLPAPQ?PSNCRSPRLRSVPAVR 
1 -------H:LQASVf'I?AiiAAt.PS£'RNIA'l'FtNt.HRPSSSP'1'1SPLt.f.II?LRIIP1'tSTS.aSI!"t' 
-------tiQATI~SQSVQCLAf'PGRAPHAHVl\NNKPPHI..RFSLFNPNRSPSSPPRLRLSSP 
-------------------------MFLQVTGTA.1'PAMPAVVPLNSWRRPLSIPLRSVK'I' 
----------------- -------- -HIRVTGTMPJI.MS -VVFPTS'WRQPVl~LPt.RSAKT 
1 --------------------------HLKATGTVlU'.!\HH-VVPPCFSSRPt.ILPLRSTKT 
-------------------------HE'QATSTGAQIMR-AAP'PRSWRRGHVuPLRSAKI 
-----MHRQIWRU.PSJ\LSPIRAGAPRPSRPPARLGRPSPQRRRJ\LJ\LTRIJ\'l'RRTCRLL 
54 
43 
l 
1 
1 
61 
54 
54 
54 
36 
34 
34 
34 
56 
113 
102 
46 
49 
46 
120 
113 
111 
113 
95 
93 
93 
93 
llS 
ol5 
ol7 
170 
159 
103 
106 
103 
177 
170 
168 
170 
152 
150 
150 
150 
172 
103 
107 
Figure 15. Protein sequence alignment of SLMKS2 and SHMKS2 with related proteins 21 • 
The white letters on black background indicate conserved amino acid substitutions. The asterisk refers to the catalytic Asp residue 
identified in 4-hydroxybenzoyl-CoA thioesterase. At, Arabidopsis thaliana; Atr, Amborella trichopoda; Gh, Gossypium hirsutum; 
Gm, Glycine max; HI, Humulus lupulus (cv Phoenix); Os, Oryza sativa; Pa, Prunus anneniaca; Pi, Petunia integrifolia subsp. inflata; 
Pg, Picea glauca; Ps, Pseudomonas sp. (strain CBS-3); Sh, Solanum habrochaites; SI, Solanum lycopersicum; SsDHNACT, 
Synechocystis sp. PCC6803 I ,4-dihydroxy-2-naphthoyl-CoA thioesterase; Vv, Vi tis vini fera. Accession numbers are as follows: Atr, 
FD440753; Gh, DT554179; Gm, AW394535; HI, EX521228; Os, CAEOI692; Pi, AAS90598; Pg, EX412733; SsDHNACT, 
NP442358; Vv, CA042155. 
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These enzymes also had similarities to other thioesterases found in other 
Kingdoms. A BLAST algorithm was performed to search for proteins with similar 
sequences outside of plants, and it was found that MKS2 is 34% identical and 48% 
similar to more than 131 aligned residues of a putative thioesterase expressed by Thermus 
thermophilus. This putative thioesterase is also 26% identical and 51% similar to 4-
hydroxybenzoyl-CoA thioesterase, supporting the notion of the homology ofMKS2 to 4-
hydroxybenzoyl-CoA thioesterase. The study implied the cooperation of both the MKS2-
class of enzymes and the previously identified MKS 1-class of enzyme with regards to 
methyl ketone production from 3-ketoacyl-ACP. Though unconfirmed, they suggest a 
mechanism in which, similar to that of bacterial methyl ketone synthesis, one enzyme 
(putatively, both SHMKS2/SLMKS2) hydrolyzes the thioester bond to produce 3-
ketoacid, which gets decarboxylated by MKS 1. Recent, unpublished data showing high in 
vitro decarboxylase activity of MKS 1 and low decarboxylase activity of MKS2 seems to 
support this hypothesis. 
z.s 
1.5 
0.5 
ShMKSl ShMICS2! 
Figure 16. In vitro assays for decarboxylase activity of SHMKS2 and MKSl 
(Picbersky, unpublished) 
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I 3.2.3. Methyl ketones in Animalia 
I 
Many mammals produce acetone during fatty acid degradation by 
decarboxylation of acetoacetic acid, the remaining intermediate in the last cycle of beta-
oxidation. This precursor can also come from the degradation of the amino acids leucine, 
isoleucine, lysine, phenylalanine, and tyrosine. Thus far, acetone is the only methyl 
ketone that has been detected in animal tissue. Though the enzymes responsible for this 
conversion have been isolated, acetone does not fit within the particular framework of 
this study. 
Methyl ketones are also found in insects, where they are found as components in 
volatile secretions such as pheromones. 2-Heptanone has been found in honeybees and in 
ants Atta texana 60• 61 . 2-Tridecanone, 2-pentadecanone, and 2-heptadecanone have been 
found in the secretions of the ants Acanthomyops claviger and in Las ius foliginosus 62• 63 . 
In general, many other insect secretions have been found to contain methyl ketones 
spanning 2-butanone to 2-heptadecanone. However, these studies have only been limited 
to the identification of the secretion constituents, and no enzyme isolation or 
characterization studies have been done regarding the methyl ketones found in the 
secretions, and the reactions leading to the synthesis of these compounds have not been 
reported. 
J3.2.4. Methyl ketones in Fungi 
i 
The study of methyl ketone production by fungi precedes the analogous studies in 
bacteria, receiving much attention since the early 1900s. Based on isotope studies and 
experiments with enzyme preparations from various fungi in the 1960s, it is now widely 
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accepted that methyl ketones produced from fatty acids by molds proceeds via the fatty 
acid degradation pathway (Figure 17) 64. The process is widespread among filamentous 
fungi; one study found 30 out of 38 fungi tested converted fatty acids to methyl ketones. 
Another study showed 9 out of 11 Aspergillus species and 9 out of 12 Penicillium species 
also carried out the transformation 65 . In general, most literature on the subject focuses on 
these two genera. 
LIPIDS 1 L1PA$f 
fATTY AciDS 
DATION 
THIOLASE Acy~-(o.l + AcETYL-Coo\ T~:.:;;, _____ _ ./ J," 
·~~· /,=' 2-~0WOONE / Ki 
Figure 17. Proposed pathway to methyl ketone from lipids or fatty acids in fungi. Broken line 
indicates possible inhibition of thiolase (thioesterase) by acyl-Co A 66 
In these molds, beta-ketoacyl-CoA thioesterase activity (labeled thiohydrolase in 
Figure 17) greatly exceeds that of thiolase, and the beta-ketoacid decarboxylase 
apparently causes rapid decarboxylation, preventing the accumulation of beta-ketoacids. 
Though studies to date have shown beta-ketooctanoyl-CoA to be the preferred substrate 
for the thioesterase, methyl ketones of varying chain lengths are formed from long-chain 
fatty acids at successive cycles of fatty acid degradation 67 • Thus, of the methyl ketones 
found, heptan-2-one is usually the most abundant, followed by nonan-2-one, penta-2-one, 
and undecan-2-one (Figure 18). However, as aforementioned, the genes for the 
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thioesterase and decarboxylase have yet to be discovered, and all studies thus far have 
been limited to assays using enzyme isolates. A GenBank and Brenda search for 
thioesterases acting on ketoacyl-CoA and decarboxylases acting on beta-ketoacids yield 
no results, not only for Penicillium and Aspergillus but all the organisms in the database. 
Considering the long history of research on methyl ketone-producing molds, it seems 
there is little motivation in the area of food science to identify the genes responsible for 
coding the beta-ketoacyl-CoA thioesterases and beta-ketoacid decarboxylases. 
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Figure 18. Rate of accumulation of different methyl ketones during ripening of cheese samples 66• 
,---------------------------------------------------------------------
13.2.5. Methyl ketones in Archaea/Bacteria 
This section will focus on current knowledge of enzymes responsible for methyl 
ketone production in bacteria. Many bacteria have been found to produce a variety of 
methyl ketones from acetone to 2-pentadecanone. However, there is a certain disparity 
between the amount of species that are known to produce methyl ketones, and the amount 
of species for which the responsible enzymes have been characterized (the latter amount 
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being much smaller). Thus, there will be more focus on the bacterial species for which 
the enzymes have been characterized and less on those which have currently only been 
shown to produce methyl ketones i.e. through cell-free extract activity assays. 
The first pathway of Figure 13 shows methyl ketones derived from secondary 
alcohols such as 2-propanol, 2-butanol, 2-pentanol, and 2-hexanol by secondary alcohol 
dehydrogenase. Many species have been found to show this type of activity, and include: 
Brevibacterium sp., Nocardia paraffinica, Pseudomonas jluorescens, Pseudomonas 
maltophilia, Pseudomonas multivorans, Mycobacterium sp., Candida uti/is, Hansenula 
polymorpha, Pichia sp., Torulopsis sp., Kloeckera sp., Thermoanaerobium sp., and some 
methylotrophic bacteria including Methylosinus trichosporium, Methylosinus sporium, 
Methylocystis parvus, Methylomonas methanica, Methylomonas a/bus, Methylobacter 
capsulatus, and Methylobacterium organophilum 55• 68-71 • All the aforementioned species' 
secondary alcohol dehydrogenases are NAD-dependent with the exception of 
Thermoanaerobium's, which is NADP-dependent, and almost all are specific to alcohols 
of six carbons or less, with the highest rates of oxidation for 2-propanol and 2-butanol. 
Most studies of these organisms have been limited to enzyme assays of cell-free extracts 
or purified enzyme, but a select few have been investigated further. One of the well-
studied species among these is Pseudomonas fluorescens, with its genome being fully 
sequenced in 2005 72• It is a Gram-negative, obligate aerobe that primarily resides in soil 
and water, but can be found in many other places due to its versatile metabolism. In P. 
fluorescens and all the other preceding organisms, the secondary alcohol dehydrogenase 
specific to alkan-2-ols is important as it catalyzes a step in their alkane degradation 
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pathway, which converts alkanes to free fatty acids for beta oxidation, as shown in 
pathway 2 of Figure 19 73• 
Pathway 1: Pathway 2: 
tennlnal oxidation subtenninal oxidation 
~ 
/ Monooxygenase ~ OH 
~OH ~ 
ADH 1i 1 ADH 
0 ~0 ~ .. Jl 
n /~n" 
ADH21 1 BVMO 
~oH --'M~I( 
1 0 1 0 Esterase 
fklxidation --'MOH + )l 
~ ~~-,~ 
~OH 
Figure 19. Alkane degradation pathway 73 
In a recent study, Escherichia coli was successfully engineered to degrade 
secondary alcohols 2-decanol and 2-dodecanol into 1-octanol and 1-decanol 
respectively73 • The genes of the secondary alcohol dehydrogenase (adhFJ), Baeyer-
Villiger monooxygenase or BVMO (bmoFJ), and esterase (estFJ), the sequences of 
which can be found in NCB I' s GenBank, were sub-cloned into a vector and 
recombinantly expressed in E. coli. The data pertaining to the conversion of secondary 
alcohols to primary alcohols in the engineered E. coli strain is summarized in Figure 20. 
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Figure 20. Conversion of decan-2-ol and dodecan-2-ol in the engineered E. coli strain 73 
Though the engineered E. coli produced primary alcohols as the end product 
instead of ketones, it can be assumed from the study's data that recombinantly expressing 
only the dehydrogenase would yield an E. coli that produces methyl ketones from 
secondary alcohols. With the addition of the monooxygenase that subterminally oxidizes 
alkanes, the E. coli may be able to produce methyl ketones from alkanes. 
The second pathway of Figure 13 shows methyl ketones derived from 
decarboxylation of beta-ketoacids. The beta-ketoacids used in bacteria that produce 
methyl ketones this way are thought to be generated by the hydrolysis of the thioester 
bond in beta-ketoacyl-CoAs (an intermediate in the fatty acid degradation pathway) by 
thioesterase, and this pathway is shown best in Figure 12 54• The bacterial species that are 
known to include both these reactions are many. Cyanobacteria and actinomycetes 
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produce 3-pentanone and 3-octanone 74• Certain Serratia strains produce 2-nonanone, 2-
undecanone, and 2-dodecanone 75 • Staphylococcus carnosus produces 2-pentanone from 
ethylbutyryl acetate or acetone from acetoacetate 76• Similarly, Clostridium 
acetobutylicum has a well-characterized acetoacetate decarboxylase (known gene 
sequence) that catalyzes the formation of acetone 52• Unfortunately, many of these studies 
(with the exception of the Clostridia study) have been limited to enzyme assays using 
cell-free extracts. In general, the genes responsible for coding beta-ketoacid 
decarboxylases in both bacteria and fungi are unknown, as a quick search of GenBank's 
database will show. 
The third pathway in Figure 13 is not yet known to occur in any bacteria, though 
it has been found to occur in plants 20 • 
Though not considered in the experimental portion of this study, tracetic acid 
lactone is still worth mentioning due to it being a polyketide-based platform chemical and 
also because it can benefit from the metabolic engineering strategies and knowledge 
gained from the methyl ketone study. Triacetic acid lactone is currently manufactured 
industrially through a series of five steps starting with the pyrolysis of acetic acid.23 
Microbial synthesis of TAL has been found to occur in Gerbera hybrida, through an 
enzyme isolated as 2-PS encoded by the g-2-ps-1 gene.24 In addition, the genetic 
modification of 6-MSAS, encoding the enzyme 6-methylsalycilic acid synthase from 
Penicillium patulum, and fasB, encoding the Brevibacterium ammoniagenes fatty acid 
synthase B, has been determined to have TAL-synthesizing activities that are not found in 
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their native forms. The pathways from each of these enzymes are shown in Figure 21. 
Synthesis of TAL in E. coli has only been preliminarily studied, through the heterologous 
expression of only 2-PS in a wild-type host. Unfortunately, the study concluded that the 
production of TAL was insignificant and thus did not report any additional information 
regarding TAL production in E. coli from the heterologous expression of these enzymes. 
However, applying metabolic engineering has the potential to enhance TAL production 
within E. coli, and thus is suitable as a future work outside of this study. 
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Figure 21. TAL synthesis routes 
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The understanding of the fatty acid biosynthesis cycle is critically important in the 
context of producing methyl ketones as it is the direct supplier of the methyl ketone 
precursor, 3-ketoacyl-ACP. Fortunately, there is much literature on the subject, and in 
recent years, several groups have introduced a variety of modifications that have 
increased yields of fatty acids. The following section reviews some of these 
developments. 
,3.4.1. The reaction pathways 
Figure 22 shows the two pathways regarding the initiation reactions to produce 
fatty acid chains, separated for clarity. The overall balance from glucose is shown in 
Figure 31. As in plants, fatty acids in E. coli are produced exclusively from acetyl-CoA 
with NADPH as the source of reducing equivalents. The fatty acid synthase system in E. 
coli is of the "type II", also known as dissociated fatty acid synthase systems. As opposed 
to the mammalian fatty acid synthesis which is catalyzed by individual domains of a very 
large polypeptide, the reactions in bacteria are catalyzed by separate enzymes encoded by 
unique genes. However, there are usually multiple proteins that catalyze the same 
chemical reaction, though the difference in substrate specificities allows the regulation of 
the range of products produced by the pathway. 
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Figure 22. Fatty acid biosynthesis separated into initiation and elongation cycles. 
(source: ecosal.org) 
Acetyl-CoA carboxylase (ACC) catalyzes the first committed, irreversible step of 
the pathway, forming malonyl-CoA in an A TP-dependent manner 29. The ATP-dependent 
carboxylation adds one more carbon, which is lost later during condensation with the 
growing acyl-ACP. It is a two-step reaction, involving the enzyme prosthetic group 
biotin. The ATP-dependent carboxylation of biotin occurs at one active site, followed by 
the transfer of the carboxyl to acetyl-CoA at a second active site. Biotin is connected to 
the enzyme by an amide bond between the carboxyl of the biotin side chain and the 
amino group of a lysine residue, which makes the biotin into an arm that can "swing" 
between the two active sites 77• The overall reaction is as follows: 
HC03- + ATP + acetyl-CoA => ADP + P1 + malonyl-CoA 
The malonyl-CoA is then made available for its condensation with acetyl-CoA by 
FabD, a malonyl-CoA:ACP transacylase. This condensation reaction forms the initial 
molecule that enters the elongation reactions. 
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The elongation reactions are shown to the left of Figure 22. The first step involves 
condenstion of malonyl-ACP with the growing acyl-ACP chain by a beta-ketoacyl-ACP 
synthase. This is the only irreversible reaction in the elongation process, and thus it is key 
in regulating the product spectrum of the pathway 17• The resulting 3-ketoacyl-ACP is 
reduced by an NADPH-dependent beta-ketoacyl-ACP reductase, and then dehydrated by 
beta-hydroxyacyl-ACP dehydratase. A fmal reduction takes place, catalyzed by enoyl-
ACP reductase to form acyl-ACP, which can undergo another round of the elongation 
cycle. It is known that these reactions can be catalyzed by a number of isozymes differing 
in their substrate specificities, though at the moment only the initial condensation 
reaction has been found to be catalyzed by more than one enzyme. However, it is 
probable based on genetic and biochemical evidence that at least three beta-ketoacyl-
ACP synthases and at least two beta-hydroxy-acyl-ACP dehydratases exist 17• 
The final step in the fatty acid biosynthetic pathway for the production of fatty 
acids is the cleavage of the thioester bond of acyl-ACP by thioesterases. Again, there are 
at least two thioesterases expressed in E. coli that act upon acyl-ACPs, but differ in their 
substrate specificities. The genes known to express enzymes involved in fatty acid 
synthesis are listed in Table 3. 
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Table 3. Fatty acid synthesis-related proteins and their known functions 17• 
Ocuo Protem or fmlc:tlon alfecwl Map M-bioc:llemlcal or ...,..U. pbcDotype positiclll 
IUI.J Acyl-ACP syatbetase 61 Accwnulatioll of lysopholpbatidyl elhaaolamiue 
IlCeA Acetyi-CoA carbollylase 4 CatboxyltraDSferue .. subunit 
tiCCB Acetyi-CoA carboJlylase 71 BCCP subunit 
eu:cC Acetyl-CoA carbollylase 71 Biotin carboxylue subunit 
4CCD Acetyl-CoA carbollylase so CatboxyltraDSferue IS subunit 
«pP ACP 24 ACP structural pae 
acpS ACP syatbetase 43 Accwnulatioll of apo-ACP 
cfa Cyc:lopropue fatty acid syalhase 36 Cella lact c:yclopropaDe fatty acids 
/tiM ~Hydrollydecanoyl ACP dehydrase 22 Uusaturated fatty acid auxotroph foMup Ovcrproductioa of saturaled fatty acids 
firbB ~Ketoacyi·ACP syalhase I so Unsaturaled fatty acid auxotroph 
fabD Maloayi-CoA:ACP traasac:ylaso 24 Ts" auxotroph reqairiq both saturaled and 
Ulllaturaled fatty acids 
{abE Acetyl-CoA carboxylase 71 Now dcsipaled 4CCB 
firbF ~Ketoac:yl-ACP syalhase II 24 Altered thermal regulatioa 
fabG ~Ketoacyi·ACP mkoclase 24 firbH ~Ketoac:yl-ACP syalhase m 24 
fiiiiR Tramcriptioaal regulator of /tiM 26 
fatA 69 Utillzatioa of muuoiiJIIaturated fatty acids 
¥teA UDP-GJo.NAc ac:yltrauferaae 4 Accwnulatioa of Upid A 
orf-17 Putative dehydrase 4 Unlmowa 
plsB .m-Glyc:crol-3-pbospbate B4:Jitra11Sferaae 92 ~rol-3-pbospbate auxotroph 
plsC 1-AcylclyceJOl pbospbate acyltraDSferase 6S 
pl.rX Unlmown 24 Required for PlsB- phenotype 
terA Tbioeaterase I 12 Defective enzyme ac:tivity 
taB Tbioeateraae II 10 Defective enzyme ac:tMty 
• Ts, lelllpenlure ICIIIIIhre. 
13.4.2. Regulation of fatty acid biosynthesis 
The entire pathway is regulated by a slew of mechanisms. Pathway enzymes are 
feedback-inhibited by long-chain (> 12 carbon) acyl-ACPs, and high level expression of 
acyl-ACP thioesterases, which convert acyl-ACPs to fatty acids, can relieve this 
inhibition. There are also implications of associated induction of fatty acid degradative 
pathways with fatty acid overproduction. In general, however, regulation of fatty acid 
biosynthesis is most affected at an early step in the process, and several pieces of 
evidence support this 78• 79• Measurement of acyl-ACP pool size and composition has 
shown that it is primarily composed of short-chain acyl-ACPs. However, long-chain acyl-
ACPs accumulate in vivo when utilization through glycerolphosphate acyltransferase is 
blocked 78 • 
As acetyl-CoA carboxylase catalyzes the most important step in fatty acid 
biosynthesis, it is important to review its regulatory mechanisms. The pathways involved 
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are seen in Figure 22. The two half-reactions are catalyzed by different subunits of the 
enzyme, which is wholly composed of four different subunits (designated accA, accB, 
accC, and aceD). Unfortunately, regulation of ace is unclear. The accB and accC genes 
are cotranscribed from a promoter far upstream of accB. Transcription of all four ace 
genes is related to growth rate - that is, rate of transcription increases with the rate of 
growth 80• However, further uncertainty is introduced as the accBC operon seems to be 
regulated by a different mechanism than that which governs the accA and aceD genes 80 • 
Acetyl-CoA carboxylase is also inhibited by long-chain acyl-ACPs (along with Fabl and 
FabH).81 The effect of fatty acid production from over-expression of ACC will be 
detailed later, though in short has resulted in increases in fatty acid production. 
The balance between beta oxidation and fatty acid synthesis is mediated by two 
transcriptional regulators encoded by fadR and fabR. Fad.R is involved in the negative 
regulation of beta oxidation (fatty acid degradation) and in positive regulation of 
biosynthesis of fatty acids. Specifically, it transcriptionally activates Jab A and fabB and 
represses the beta oxidation pathway in the absence of long-chain acyl-CoAs. 16 In 
contrast, FabR inactivates/ahA andfabB. 
Over-expression of the P -ketoacyl-acyl ACP synthetases have resulted in 
inhibition of growth in E. coli. Over-expression of FabB has resulted in relatively 
moderate inhibition, though over-expression of FabF was shown to be extremely toxic to 
the cells. 82 The effect was found to be the cessation of phospholipid synthesis due to the 
blockage of fatty acid synthesis. Malonyl-CoA levels increased to about 40% of the total 
cellular pool of CoA from 0.5% without over-production. Over-production of FabD 
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partially relieved the toxicity, consistent with the theory that FabF over-production blocks 
the conversion ofmalonyl-CoA to malonyl-ACP. 
ATP + HC03• ADP + P; ~~r.CoA P-PanSH AccB AccAD AccB-C02 
AcpH AcpS ~
+-- glycolysis, 
ACP y;.: Malonyi-CoA Acetyi-CoA & tty .d A "d t• 
.a act • ..-oxt a ton 
FabD b Fa H 
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Figure 23. Overall fatty acid synthesis pathway with relevant enzymes labeled. 
The expression of FabH, FabD, and FabG is coordinated by the fabH promoter. 
During stringent response, phospholipid synthesis is inhibited. It was found that the fabH 
promoter was repressed during stringent response, resulting in the inhibition of 
phospholipid synthesis andfabDGH.83 
FabA and fabZ are two genes encoding beta-hydroxyacyl-ACP dehydratases. 
FabZ efficiently dehydrates the short chain beta-hydroxyacyl-ACPs and long chain 
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saturated and unsaturated beta-hydroxyacyl-ACPs, while FabA exhibited more activity 
on intermediate chain length beta-hydroxyacyl-ACPs but still possessed high activity on 
those that were short and long-chain.84 FabA has been over-expressed 10-fold in E. coli, 
which resulted in significant increases in saturated fatty acids in phospholipids but no 
increase in unsaturated fatty acids, indicating that the level of dehydrase activity in wild-
type cells does not limit the rate of unsaturated fatty acid synthesis. 85 Unsaturated versus 
saturated fatty acid production is known to be regulated at this pathway and is thermally 
regulated. 
J3.4.3. Over-production of fatty acids 
Recent studies have targeted some of the more obvious genotypic alterations that 
could lead to increased fatty acid production. A study in 2008 introduced the genetic 
alterations as shown in Figure 24. 
Figure 24. Lu et. al. 2008 introduced these genetic modifications for several-fold increases in free 
fatty acid production. 
(Red denotes knocked out pathways, and green denotes over-expressed pathways) 
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The fadD and glycerol-3-phosphate acyl transferase knockouts served to increase 
the pool of free fatty acids and fatty acyl-ACPs respectively, which resulted in the 
increase of free fatty acids overall. In addition, over-expression of ACC increased the 
flux from acetyl-CoA towards malonyl-CoAl ACP, the main building block of fatty acids. 
One study published in 2010 reported the development of an engineered E. coli 
strain that was able to overproduce medium-chain length fatty acids through 
overexpression of acetyl-CoA carboxylase (ACC), elimination of the beta-oxidation 
pathway through knockout offadR (the first enzyme of the pathway), and introduction of 
a plant thioesterase known to produce medium chain length fatty acids 31 • 86• The 
metabolic pathways and the pathway modifications are shown in Figure 25. 
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Figure 25. Pathway modifications introduced in Lennen et. al. 2010 31• 
The bolded arrows represent overexpressed pathways or heterologous expression (BTE), and X represents disruption by gene deletion. 
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These two studies focused on redirecting the carbon flux towards the production 
of free fatty acids, but other studies have accomplished this through increasing co-factor 
availability. It is known that NADPH is required for fatty acid biosynthesis, and a major 
supplier of it is thought to be NADP+-dependent malic enzyme 87 . One unpublished study 
over-expressed ACC, which resulted in a 3-fold increase in cellular lipids compared to 
the wild-type strain. Over-expression of E. coli's native malic enzyme resulted in a 4-fold 
increase, and co-expression of the two genes resulted in a 7.5-fold increase. 
To assess strain performance regarding the production of methyl ketones, it is 
very important to have a sensitive, precise, and accurate way to measure methyl ketone 
concentration not only of the culture media supernatant, but also from the intracellular 
component of the cells. Though there are no published methods for methyl ketone-
specific extractions from E. coli culture, many methods for fatty acid extraction have 
been documented and provide a good starting point as fatty acids are similar in structure 
and properties to methyl ketones. 
3.5.1. Lysis 
If a product is produced intracellularly and not secreted by the cell, or if the 
product is to be removed from plant, fungal, or animal tissue, then it is necessary to 
remove the product by lysis, or breaking of the cells or tissues. There are a wide variety 
of procedures to do so, broadly classified as "chemical" or "physical" methods. The 
appropriate one chosen based on the nature of the product as well as the nature of the cell 
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or tissue. In the case of methyl ketones, due to their hydrophobic nature, it is quite 
possible for them to remain in the cytoplasm as an intracellular product. 
Gram- cell 
envelope 
Figure 26. Gram-cell envelope structure. 
(source: Microbiology, with Diseases by Body System by Bauman, 2nd edition) 
Typically, bacterial cell envelopes consist of an inner plasma membrane, a 
peptidoglycan cell wall, and an outer membrane as shown in Figure 26. Bacterial cells 
with a thick cell wall are called "Gram positive" , whereas those with thin cell walls are 
"Gram negative" (the names are due to a staining procedure of the peptidoglycan cell 
wall). For example, E. coli is a Gram-negative bacterium. In general, the envelope of the 
bacterial cell is very resistant to breaking. The membranes themselves are composed of 
phospholipid bilayers, as shown in Figure 27. The stiffness of the metnbrane is conferred 
by the amount of cholesterol and other steroids that happen to exist in the non-polar layer, 
whereas flexibility is conferred by amphiphilic proteins wedged partially or wholly 
through the membrane. 
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Figure 27. Phospholipid bilayer structure. 
(source: Forschungzentrum lnstitute of Structural Biology, http://www.fz-juelich.de/isb/isb- lldatapooVpage/28/Figurel-500.jpg) 
The bacterial cell wall protects the cell from physical as well as osmotic stress. 
However, depending on the concentrations of solutes outside of the cell relative to the 
inside, water will either be drawn out or drawn into the cytoplasm. When too much water 
is drawn in, it may break the cell wall, a condition that is beneficial for harvesting the 
retained products. 
As aforementioned, various methods exist for the breakage of cells, but each are 
best suited for different applications. They differ not only their principle mode of action, 
but also in the stress they impart on the cells/tissues, their cost, and their scale. 
Though every cell has an osmotic gradient, drastic changes to extracellular 
concentrations of solutes can have disastrous impacts on cells that do not have walls, 
such as animal cells. If transmembrane osmotic pressure is related to the solute 
concentration inside and outside the cell, van't Hoffs law can be used to estimate this 
osmotic pressure: 
where pi is the osmotic pressure, R is the gas constant, Tis absolute temperature in 
Kelvin, and Ci-Co is the difference between solute molarity inside and outside the cell. 
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Unfortunately, bacterial cells have walls which protect them against osmotic lysis. 
However, there are other methods to destroy this wall. 
Enzymatic lysis can be achieved with the addition of the enzyme lysozyme, which 
is readily available commercially. However, these are not suitable for applications that 
require the harvesting of proteins. 
Detergents are another way to lyse cells, though they are limited to animal cells in 
application as they act on plasma membranes. Typically, detergents such as Triton X-100 
are used, though it is mainly a trial and error process as different proteins react differently 
depending on the detergent used. 
Finally, and most relevant, is the use of solvents for lysis of cells. An addition of 
an organic solvent, for example, can dissolve membranes which can be of use after 
mechanical breaking of cell walls. Benzene, the organic solvent used in this study, is 
known also to permeabilize cell walls 88• 
13.5.2. Extraction 
Methyl ketones are in general organic liquids that are insoluble in water but quite 
soluble in common organic solvents such as ethanol, chloroform, benzene, and acetone. 
In this scenario, liquid-liquid organic extraction is the most suitable tool for extracting 
methyl ketones. Liquid-liquid extraction is a mass transfer process wherein a liquid 
solution (feed) is contacted with an immiscible liquid (solvent) that exhibits higher 
affinity towards the desired solute in the feed. The end result is two streams: the extract, 
which is the solvent containing the extracted solute, and the raffmate, which is the 
residual feed minus the extracted solute. However, operating conditions such as solvent 
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type, contact time, and mixing method need to be carefully evaluated and optimized for a 
given feed and solute. 
Currently, most of the scientific community uses a rapid and reproducible method 
developed by Bligh and Dyer in 1959 for the extraction of fatty acids from fish tissue 89. 
In this method, fatty acids are primarily extracted from tissue using a chloroform-
methanol solution. The chloroform-methanol solution, when added to tissue (primarily 
composed of water), results in a homogenous, monophasic system, which they 
hypothesized correctly to give optimum lipid extraction. The subsequent addition of 
water and/or chloroform turns the mixture into a biphasic system, from which the organic 
layer now rich in lipids can be taken. To be able to analyze these lipids in a gas 
chromatograph, the chloroform-methanol extract is evaporated away, the leftover lipids 
acidified to produce fatty acid methyl esters, and fmally extracted again using hexane. 
However, these last derivatization steps do not apply to methyl ketones, as they can be 
directly analyzed in a gas chromatograph. 
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4. MATERIALS AND METHODS 
Table 4 describes plasmids used in this study, which express different 
combinations of shmks2, slmks2, and mksl on plasmids with copy-numbers spanning 
from a low of -5 (pZS), to a moderate level of -15-20 (pTrcHis2A), to a high level of 
-300-500 (pCR2.1-TOPO). The pZS plasmid is a derivative ofpZA31-luc, part of the pZ 
family of plasmids 90"92 • The pTrcHis2A and pCR2.1-TOPO plasmids are supplied by 
Invitrogen (Carlsbad, California). The genes shmks2 and slmks2 are from Solanum 
habrochaites and S. lycopersicum respectively, and are 3-ketoacyl-ACP thioesterases, 
members of the alP hydrolase super-family. The gene mksl is from S. habrochaites, and 
is thought to be a beta-decarboxylase that also exhibits some thioesterase activity. All 
three genes were amplified from expression vectors supplied by Dr. Pichersky's lab 
carrying full ORFs of the three genes 21 • The gene adhFJ was amplified from pABE 
supplied by Dr. Bomscheuer lab 73 • 
The genes were cloned into the plasmids using the Clontech (Mountain View, 
CA) In-Fusion cloning framework, the general scheme of which is shown in Figure 28. 
The method is designed to join multiple pieces of DNA which have 15 bp's of homology 
at their linear ends, and is mainly used for the cloning of PCR products linearized vectors 
without the need for restriction enzyme cleavage of the insert and without the use of 
ligase or blunt-end polishing. The proprietary enzyme promotes single-strand annealing 
reactions and can assemble DNA molecules that share short sequence homologies at their 
ends. Exonuclease activity of the proprietary enzyme cleaves nucleotides from 3' ends, 
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exposing any overlapping sequence, which become free to anneal and form non-
covalently joined molecules that are repaired within the target E. coli strain. 
In case of the single-expression plasmids, a cloning site was chosen within the 
multi-cloning site upstream of the promoters and ribosome binding sites as the insertion 
site for the gene of interest, and the plasmid was linearized. For pZS, Kpnl and Mlul 
were used for linearizing the plasmid. For pTrcHis2A, Kpnl and Sall were used, and for 
pCR, Kpnl and EcoRI were used. To prepare the cloning inserts, Primer3 
(http://frodo.wi.mit.edu/primer3/) was used to design gene-specific primers flanking the 
gene of interest. Once the primer sequences were found, a 15 bp sequence homologous to 
the 3' ends of the linearized plasmid were added as shown in the first step of Figure 28. 
Following PCR amplification of the inserts, they were subsequently run on agarose gels 
to confirm successful PCR amplification and gel-purified. The inserts were then 
incubated along with the linearized vector of choice along with the In-Fusion proprietary 
buffers and enzymes for the cloning reaction. The resultant nicked plasmids were then 
transformed via heat shock into Clontech's Fusion Blue competent cells, an E. coli K-13 
strain that provides high transformation efficiency and contains recA and endA mutations, 
making it a good host for high yields of plasmid DNA. After transformation, the cells 
were plated on LB plates with appropriate antibiotics for screening of transformed cells 
for plasmids. Proper cloning of the inserts was checked through colony-PCR. 
In the case of the double-expression plasmids, the procedure was essentially the 
same except the primers used for the amplification of the second gene (mksl) involved an 
addition of a ribosome binding site consensus sequence (GAGGAG) along with 6 dummy 
base pairs between the 15 bp homology to the vector and the gene-specific priming 
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sequence 93 . The PCR insert derived from these primer sets were cloned downstream of 
the first gene's ORF (shmks2 or slmks2). In this way, an operon would be constructed 
where both genes would be transcribed and controlled under the same promoter, with 
translation occurring for the two genes on one transcript due to the ribosome binding 
sites. A map of this is shown in Figure 29. 
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Figure 28. Clontech's In-Fusion protocol. 
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Figure 29. Map of double expression operon. 
Afterwards, plasmids miniprepped from the Fusion Blue competent cells were 
transformed into MG 165 5 E. coli cells by electroporation and selected on LB plates with 
appropriate antibiotics (chloramphenicol for pZS series, ampicillin for pTrcHis2A series 
60 
and pCR series). Gene expression was induced with 100 ng/mL anhydrous tetracycline 
for the pZS series plasmids, and 100 J.!M isopropyl P-D-1-thiogalactopyranoside (IPTG) 
for the pTrcHis2A and pCR series plasmids. Plasmids miniprepped from the fmal strains 
were verified through both restriction analysis and sequencing of the operon regions. 
Table 5 contains the backgrounds, genotypes, and sources of the strains of E. coli 
used in this study. All strains used are derivatives of Escherichia coli K-12 strain 
MG 1655 (F- A..- ilvG- rfb-50 rph-1), obtained from the University of Wisconsin E. coli 
Genome Project (www.genome.wisc.edu) 94 • Mutant alleles were moved into this 
background via standard P 1 transduction as described in Blankschien et. al. 95 
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Table 4. Plasmid list. 
Plasmid Relevant information Source 
Blank plasmid created by removing C. freundii dhaKL Yazdani and pZSblank fragment from pZSKLcf and self-ligating the plasmid (tetR, Gonzalez 2008 92 
oriR SC101 *,cat) 
pZS-shmks2 Solanum habrochaites shmks2 gene under control ofPLtetO-I This study (tetR, oriR SC101 *,cat) 
pZS-slmks2 S. lycopersicum slmks2 gene under control ofPLtetO-I This study (tetR, oriR SClOl *,cat) 
pZS-mksl S. habrochaites mksl gene under control ofPLtet0-1 This study (tetR, oriR SC101 *,cat) 
pTrcHis2A- S. habrochaites shmks2 gene under control ofP1acz (lacR, This study 
shmks2 oriR BR322) 
pTrcHis2A-slmks2 S. lycopersicum slmks2 gene under control ofP1acz (lacR, This study 
oriR BR322) 
pTrcHis2A-mksl S. habrochaites mks I gene under control of P1acz (lacR, oriR This study BR322) 
pTrcHis2A- S. habrochaites shmks2 and S. habrochaites mksl genes This study 
shmks2-mksl under control ofP1acz (lacR, oriR BR322) 
pTrcHis2A- S. lycopersicum slmks2 and S. habrochaites mkslgenes This study 
slmks2-mksl under control of P1acZ (lacR, oriR BR322) 
pCR-shmks2 S. habrochaites shmks2 gene under control ofP1acz (oriR This study pUC) 
pCR-slmks2 Solanum lycopersicum slmks2 gene under control ofP1acz This study (oriRpUC) 
pCR-shmks2-mksl S. habrochaites shmks2 and S. habrochaites mks 1 genes This study 
under control ofP1acZ (oriR pUC) 
pCR-slmks2-mksl S. lycopersicum slmks2 and S. habrochaites mkslgenes This study 
under control ofPiacZ (oriR pUC) 
pZS-adhFl Pseudomonasfluorescens adhFJ gene under control of This study PLtetO-I (tetR, oriR SC101 *,cat) 
pTrcHis2A-adhF1 Pseudomonasfluorescens adhFJ gene under control ofP1acZ This study (lacR, oriR BR322) 
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Table 5. Strain list 
Plasmid Relevant information Source 
MG1655 F-1-ilvG-rfb-50 rph-1 Kang et. a!. (2004)94 
tl.adhE MG1655 tl.adhE::FRT-Kan-FRT This study 
MdhA MG1655 /1/dhA::FRT-Kan-FRT This study 
tl.poxB MG1655 tl.poxB::FRT-Kan-FRT This study 
tl.pta MG1655 tl.pta::FRT-Kan-FRT This study 
tl.adhE tl.pta MG1655 tl.adhE::FRT tl.pta::FRT-Kan-FRT This study 
MdhA tl.poxB MG1655 /1/dhA::FRT tl.poxB::FRT-Kan-FRT This study 
MdhA tl.poxB tl.pta MG1655 /1/dhA::FRT tl.poxB::FRT tl.pta::FRT This study 
tl.adhE MdhA MG1655 tl.adhE::FRT /1/dhA::FRT tl.poxB::FRT tl.pta::FRT This study 
tl.poxB tl.pta 
,4.2.1. Culture Media 
All work was done at 37°C with either LB medium or MOPS minimal medium 
(below), supplemented, when required, with sodium citrate (5-20 mM, for phage P1 
transductions), ampicillin (50 ug/mL), chloramphenical (34 uglmL), glucose (10 giL 
unless otherwise stated), IPTG (0.1 mM), and anhydrotetracycline (100 ng/mL). The 
minimal media designed by Neidhardt (MOPS) was supplemented with 1.32 mM 
63 
stated 96• All chemicals for culture media were from Fisher Scientific (Pittsburgh, PA) 
and Sigma-Aldrich Co. (St. Louis, MO). 
Long-term storage of strains was accomplished by preparing glycerol stocks as 
described in Current Protocols in Molecular Biology 97• Glycerol stock media was 
prepared as a filter-sterilized 2x solution containing 65% (v/v) glycerol, 0.1 M MgS04, 
and 0.025 M Tris-HCl pH 8. Equal amounts of this solution and media containing 
exponentially growing cultures (OD -0.5) were combined and subsequently stored at -80 
°C for future use. These stocks were used to streak media plates containing 10 g/L NaCl, 
5 giL yeast extract, 10 giL tryptone and 1.5% agar. When required, antibiotics were 
included in the following concentrations: 100 ).lglmL ampicillin, 34 ).lglmL 
chloramphenicol, 50 ).lglmL kanamycin, and 12.5 ).lglmL tetracycline . 
. Calcium carbonate, which is biologically inert, was added at a concentration of 
50 giL for pH control of flask cultures, unless otherwise stated. 
j4.2.2. Cultivation conditions - Shake flask experiments 
Prior to inoculating starter cultures, frozen stocks (stored as glycerol stocks at -80 
0 C) were streaked onto LB plates (with appropriate antibiotics if required) and incubated 
overnight at 37 °C. A single colony was used to inoculate the starter culture flasks. 
Starter cultures were cultivated in LB with appropriate antibiotics at a 10 mL 
working volume in 25 mL Erlenmeyer flasks. The operating conditions were 37°C at 200 
RPM in a New Brunswick Scientific (Edison, NJ) benchtop incubator. Starter cultures 
were taken out during exponential phase (OD -0.5), and depending on the working 
volume of the experimental flask culture to be inoculated, a certain volume was pelleted 
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down at 6000 g for 4 min to inoculate the experimental flask cultures to an OD of0.05. If 
the experimental flask culture media was minimal media (MOPS supplemented as stated 
above), the pellets were washed twice with the minimal media (centrifuging at 6000 g for 
4 min each time) to reduce the increased lag phase the cells may experience when 
switching to different media. 
The experimental flask cultures were cultivated in either minimal media or LB-
Miller with appropriate antibiotics at various working volumes in 125 mL Erlenmeyer 
flasks. The operating conditions were 37°C at 200 RPM in a New Brunswick (Edison, 
NJ) benchtop incubator. 
4.2.3. Cultivation conditions - Fermentor experiments 
Prior to inoculating starter cultures, frozen stocks (stored as glycerol stocks at -80 
0 C) were streaked onto LB plates (with appropriate antibiotics if required) and incubated 
overnight at 37 °C. A single colony was used to inoculate the starter culture flasks. 
Pre-starter cultures were cultivated in LB-Miller with appropriate antibiotics at a 
10 mL working volume in 25 mL Erlenmeyer flasks. The operating conditions were 37°C 
at 200 RPM in a New Brunswick Scientific benchtop incubator. Pre-starter cultures were 
taken out during exponential phase (OD -0.5), and depending on the working volume of 
the experimental flask culture to be inoculated, a certain volume was pelleted down at 
6000 g for 4 min to inoculate the starter cultures to an OD of0.05. Pre-starter culture was 
required for reasonable growth time in the primary starter culture grown in MOPS 
minimal media, described below. 
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The starter cultures were cultivated in MOPS minimal media as described 
previously with 10 giL glucose and appropriate antibiotics. The operating conditions 
were 37°C at 200 RPM in a New Brunswick benchtop incubator. Starter cultures were 
taken out during exponential phase (OD -0.5), and depending on the working volume of 
the experimental flask culture to be inoculated, a certain volume was pelleted down at 
6000 g for 4 min to inoculate the fermentor cultures to an OD of 0.05. MOPS minimal 
media was used for the primary starter culture to decrease the lag time between 
inoculation and exponential phase in the fermentor. 
The fermentor cultures were cultivated in a Infors HT (Bottmingen, Switzerland) 
Sixfors bench-top six bioreactor setup. Each vessel was fitted with an impeller, dissolved 
oxygen probe, pH probe, acid and base inlets, condenser with headspace outlet, gas inlet 
(submerged for sparging of media), temperature probe, and submerged outlet tube for 
culture collection. Externally, a magnetic stirrer and thermo-electric block provided 
impeller RPM and temperature control, respectively. A .45 micron filter was attached to 
the headspace outlet from the condenser, and a .2 micron filter was attached between the 
gas inlet and the gas source. The controlled variables included pH, dissolved oxygen, 
and temperature, and these variables were constantly measured through the Sixfors 
computer via sensor attachments. pH was adjusted with either 1.5 M sulfuric acid or 3 M 
sodium hydroxide. Dissolved oxygen was controlled by RPM adjustment between 200-
800 via the Sixfors microcontroller. From inoculation, air was supplied at a rate of 
approximately .5 Llmin by an external air pump. Over the course of fermentation, 
maintenance of dissolved oxygen levels required the sparging of pure oxygen (Oxygen, 
compressed, ultra high purity, Matheson Tri-Gas). Fermentor conditions were carefully 
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monitored over the course of the entire fermentation to see when such a switch from air 
to oxygen was necessary. The oxygen was provided at a rate of between 0.1 Umin to 0.5 
Umin, manually adjusted during the fermentation to keep dissolved oxygen levels 
constant. 
4.3.1. Lysis methods 
The mechanical breakage of cells was conducted using the Disruptor Genie 
(Scientific Industries Inc., Bohemia, New York) with 0.1 mm diameter glass beads 
(Scientific Industries Inc., Bohemia, New York) designed for bacterial cells. Assessment 
of the optimal operating conditions for the ball mill method was done by varying time of 
disruption (power level is constant and cannot be changed by the user). 
Sonication was assessed using the Branson Sonifier 450 (Emerson Industrial 
Automation, Danbury, CT) with the tip attachment. As the equipment literature stated, 
the area-of-effect of the sonicator is shaped like a cone projecting from the botton of the 
tip. Thus, the tip was inserted approximately 1 em into the samples, the minimum depth 
recommended by the manufacturer (twice the diameter of the tip). The equipment 
literature stated typical complete bacterial cell breakage will occur at 45 seconds of 
sonication. With cell culture volume and power setting fixed, time of sonication was 
varied from 0, 45, 90, and 180 seconds for various ODs. Duty cycle (the portion of each 
second during which the sonication occurs) was set to 30% so as to give the sample time 
to cool. 
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,4.3.2. Extraction methods 
Benzene, n-hexane, and chloroform were obtained from Sigma-Aldrich Co. (St. 
Louis, MO). Significant operating conditions such as vortex time and solvent/feed 
volumes were varied, keeping all factors regarding the feed constant across all the 
variations. Vortex time was varied from 0, 30, 60, 90, 120, and 150 seconds. Solvent/feed 
volume was determined using an iterative process, steadily increasing the culture volume 
while keeping solvent volume constant at 1 mL such that the peak reading becomes 
reliable on the GC-FID. All other equipment and methods regarding the extraction can be 
found in section 3.4.2. 
J4.4.1. Optical density, pH, and HPLC analysis 
Optical density was measured at a wavelength of 550 nm on a Genesys 
spectrophotometer and used as an estimate of cell mass (1 OD550 = 0.34 g dry weight/L). 
When required, the pH of samples were measured using a Denver UB-I 0 pH meter 
(Denver Instruments, Denver, CO). After centrifugation of the sample, the supernatant 
was stored at -20 oc for future HPLC analysis. Quantification of the concentration of 
glucose and other compounds was accomplished with ion-exclusion HPLC by injection 
of 10 IJ.L of sample through a Shimadzu Prominence SIL 20 system (Shimadzu Scientific 
Instruments Inc., Columbia, MD) equipped with an HPX-87H organic acid column (Bio-
Rad, Hercules, CA). Operating conditions were optimized for adequate peak separation 
(30 mM H2S04 in mobile phase at 0.3 mUmin, column temperature 42 °C), previously 
determined by Dharmadi and Gonzalez 98 • 
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14.4.2. Extraction of methyl ketones in culture 
The whole process of extraction, identification, and quantification starts with at 
least 15 mL of culture for accurate analysis. For example, to run an analysis of a flask 
culture with a working volume of 10 mL, another replicate must have been run in parallel 
to meet the 15 mL culture requirement for analysis. This is to adequately acquire the 10 
mL requirement for extraction and the 2 mL required for supernatant storage for future 
HPLC analysis. 
Extraction began with splitting 10 mL of culture into two 5 mL aliquots each in 
14 mL round-bottom polypropylene Falcon tubes, which are wide to prevent the 
sonication tip from hitting the walls. Each Falcon tube holding 5 mL of culture was 
placed in an ice bath and set in a Branson Sonifier 450 (Emerson Industrial Automation, 
Danbury, CT) such that the sonicator tip was approximately 1 em deep and centered. The 
sample was subsequently sonicated for 5 minutes at a duty cycle of 30% and a power 
setting of 1. 
Once sonication was complete for both 5 mL aliquots, they were combined into a 
15 mL Coming CentriStar centrifuge tube (Coming Inc., Lowell, MA) for the liquid-
liquid extraction. 1 mL of benzene ( deuterated when preparing samples for NMR 
analysis) was added, and the solution vortexed for 2 minutes. Afterward, the solution was 
placed on a Thermo Scientific Barnstead Labquake rotisserie (Thermo Fisher Scientific 
Inc., Asheville, NC) for 1 hour to maximize methyl ketone transfer and to allow the 
aqueous and organic droplets to settle. Finally, the solution was centrifuged for 15 
minutes at 12,000 g to separate the phases, and the organic phase recovered. 
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The recovered extract was placed in a 2-mL screwtop PTFE glass vial and stored 
at -2ooc for future GC-MS/FID or NMR analysis. The overall flow of this procedure is 
shown in Figure 30. For preparation of supernatant feed (as opposed to the sonicated 
whole culture feed), the culture liquid was spun down at 12,000 g for 5 minutes in 15- or 
50- mL Corning CentriStar centrifuge tubes (Corning Inc. , Lowell, MA), and the 
appropriate volume of supernatant recovered. 
•
1 
Lysis/permeabilization 
Sonication 
' Liquid-liquid extraction 
Organic extraction using benzene 
: Quantification/Identification 
GC-FID GC-MS NMR 
Figure 30. Extraction, identification, and quantification protocol at a glance. 
14.4.3. Identification of methyl ketones 
Identification of methyl ketones consisted of two approaches: one from GC-MS, 
and another through one-dimensional proton NMR. The NMR results provided structural 
verification by confmning the presence of the first 5 methyl ketone carbons, and the GC-
MS provided total mass information which revealed the chain lengths of the methyl 
ketones present in the sample. 
GC-MS was conducted by injecting 1 J..LL of sample through a Shimadzu GCMS-
QP20 1 OS (Shimadzu Scientific Instruments Inc., Columbia, MD) equipped with an 
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Agilent DB-5 {Agilent Technologies, Foster City, CA) (5%-Phenyl)-methylpolysiloxane, 
non-polar, high temperature column. The carrier gas was helium, and the injector was set 
to hold at 250°C for 0.5 min, ramp to 280C at SOC/min, and hold for 1 min. The column 
oven was set to initialize at 50°C, hold for 5 min, then ramp to 275 at a rate of 
3.75°C/min. Total time per sample was approx 65 min. Identification of compounds was 
conducted using the similarity search algorithm through built-in libraries of Shimadzu's 
GCMS Solution software. Peaks that came up as methyl ketones in the similarity search 
were further confirmed by comparing their retention times with those from methyl ketone 
standards. 
NMR was conducted by aliquoting approximately 600 f..i.L of extract (using 
deuterated benzene) in a glass NMR tube for reliable shimming of the sample, and a 
Varian Inova 500 (500 MHz NMR) equipped with a HCNP quad probe (Varian Inc., Palo 
Alto, CA) was used to obtain the 1-D proton spectra. The following parameters will be 
utilized: 25°C sample temperature, 8,000 Hz sweep width, 2.8 s acquisition time, 256 
acquisitions, 6.3 f..I.S pulse width, 1.2 s pulse repletion delay, and presaturation for 2 s. 
Prior to running the samples, methyl ketone standards at a concentration of 50 mg/L were 
used to identify the signature peaks and their associated J -coupling and chemical shift 
values. 
4.4.4. Quantification of methyl ketones 
Quantification of methyl ketones was primarily done by injecting 1 f..I.L of sample 
through GC-FID analysis using a Varian CP-3800 GC (Varian Inc., Palo Alto, CA) with 
ari FID back-end and equipped with a Varian VF-Sht 5% phenyl methyl 
dimethylpolysiloxane, non-polar, high temperature column. Prior to sample analysis but 
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following temperature program optimization, standards of 3 methyl ketones (2-nonanone, 
2-undecanone, 2-tridecanone) with concentrations of 5, 10, 20, 50, and 100 mg/L were 
injected. The peak areas were calculated through the Varian GC software and calibration 
curves made to relate peak area to methyl ketone concentration in benzene. The carrier 
gas was helium, and the injector was set to hold at 250°C for 0.5 min, ramp to 280C at 
SOC/min, and hold for 1 min. The column oven was set to initialize at 50°C, hold for 5 
min, then ramp to 275 at a rate of3.75°C/min. Total time per sample was approx 65 min. 
14.5.1. E. coli extract preparation 
I 
Prior to inoculating starter culture, frozen stocks (stored as glycerol stocks at -80 
°C) were streaked onto LB plates (with appropriate antibiotics if required) and incubated 
overnight at 37 °C. A single colony was used to inoculate a 1-5 mL starter culture in LB 
media in a 15 mL conical Falcon tube overnight. A 25 mL culture of LB media 
containing 0.1 mM IPTG or 100 ng/mL anhydrotetracycline and appropriate antibiotic 
was then inoculated with 50 uL of the overnight starter culture and incubated for >2 
hours until mid-log growth (OD55o of0.5-l). 
Approximately 0.15 OD550 units of culture was spun down at 13,000 g for 1 
minute. The supernatant was removed and the pellet resuspended in 20 uL of IX 
NuPAGE LDS (Invitrogen) sample buffer with NuPAGE reducing agent (Invitrogen). 
The samples were then heated to 95°C for 15 minutes. 
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I 4.5.2. SDS-PAGE gel running conditions 
I 
The samples as prepared in the previous section were loaded into a pre-cast 
NuPAGE® Novex 12% Bis-Tris lO-well gel (Invitrogen) secured in a Xcell SureLock 
Mini Cell (Invitrogen). The upper buffer chamber was filled with approximately 200 mL 
of IX NuPAGE SDS running buffer (Invitrogen) supplemented with 500 uL NuP AGE 
antioxidant. The lower buffer chamber was filled with approximately 600 mL of IX 
NuPAGE SDS running buffer. Novex Sharp Unstained Protein standard was used as the 
protein ladder. A 200 V electric field was applied to enable separation of the proteins 
across the gel by a Fisher S~ientific FB300 power supply (Thermo Fisher Scientific), 
until the blue marker dye migrated to approximately 1 mm from the bottom of the gel. 
j4.5.3. Gel staining 
I 
Once the electrophoresis completed, the gel was washed three times for 5 minutes 
on an orbital shaker to remove SDS and buffer salts using deionized water. Afterwards, 
approximately 20 mL of SimplyBlue Safestain (Invitrogen) was decanted such that the 
gel was submerged completely, and shaken on an orbital shaker overnight at room 
temperature. De-staining was done by adding 100 mL deionized water and shaking on an 
orbital shaker at room temperature for 3-5 hours. 
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5. RESULTS AND DISCUSSION 
The knowledge of the two biochemical reactions leading to methyl ketones from 
polyketide intermediates as described in the literature21 allowed pathway analysis from 
glucose to the end product methyl ketone. Figure 31 shows the methyl ketone synthesis 
reactions attached to the polyketide synthesis cycle and the preceding glycolytic reactions 
within E. coli. 
Glycolysis 
ATP AIJP ATP A0P 
Glucose \ t • G6P F6P \ I< • F1,6BP 
ATP ADP NADH NAD"" ~ < 2PG -- 3PG ~ 1,3BPG _.LL.. GADP DHAP ><,0 AOP ATP 
PEP Pyr 
Figure 31. Overall pathway from glucose to methyl ketones. 
The top portion involves standard glycolysis connecting glucose to pyruvate, the 
precursor to acetyl-CoA which eventually becomes the indirect building block of fatty 
acids and methyl ketones. The purple circle outlines the initiation reactions that need to 
take place for both the first molecule that enters the fatty acid cycle (acetoacetyl-ACP) 
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and malonyl-ACP, the direct building block that gets added onto acyl-ACP at each turn 
of the cycle. The blue circle shows the fatty acid synthesis cycle, and the bottom circle 
outlines the irreversible "termination" reactions that lead out from the fatty acid synthesis 
cycle at 3-ketoacyl-ACP to form methyl ketones. The stoichiometric balance from 
glucose to acetyl-CoA (AcCoA), from acetyl-CoA to methyl ketones of various sizes, and 
then a combined balance from glucose to methyl ketones of various sizes was obtained by 
tracing the metabolites along the pathway. These balances are shown in Figure 32. 
• Glucose to AcCoA 
f', 
i .... 
L../ 
.. AcCoAto MK 
. ·-- ~' ..... w 
• Combining for overall balance 
j 
I , !----/ 
Figure 32. Balances from glucose to methyl ketones. 
This calculation gives the net change in co-factors and maximum theoretical 
yields, clues as to what modifications may need to be made for co-factor balance, what 
environmental conditions may be most appropriate for maximizing product yield, and 
gives upper bounds for economic purposes. The "N" corresponds to the number cycles 
the fatty acid synthesis pathway has made in order to create a C2N+J methyl ketone, as 
shown in Figure 31. This overall balance shows that: 
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• the process generates A TP independent of the chain length of the resulting methyl 
ketone, meaning the process to convert glucose to methyl ketones will most likely 
not significantly inhibit cell growth by competing for A TP with the cell's native 
anabolic processes. 
• the process generates excess reducing equivalents independent of the chain length 
of the resulting methyl ketone, meaning the conversion of glucose to methyl 
ketones will require an external electron acceptor such as oxygen. 
• the process generates excess NADH but consumes NADPH, which means 
modifications to increase the pool ofNADPH may be beneficial for production of 
methyl ketones. 
15.2.1. Selection of enzymes 
As E. coli does not natively produce methyl ketones, the first objective was to 
graft the two-step methyl ketone synthesis pathway into the wild-type E. coli strain, 
verify the expression of the enzymes, and measure their activities indirectly through 
identification and quantification of the methyl ketone products. Selection of the 
appropriate genetic sources for heterologous enzymes is generally difficult due to the 
unpredictable nature of product expression and activity within a non-native host. 
However, the possibility of constructing a functional pathway was increased by selecting 
well-characterized beta-ketoacyl-ACP thioesterases and beta-ketoacid decarboxylases 
(termed "methyl ketone synthases (MKSs)" by the authors characterizing the enzymes) 
proven to have some functionality in E. co/i.21 Previous studies had shown the presence 
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of 2-tridecanone (major product) and 2-undecanone (minor product) from heterologous 
expression of SHMKS2 (beta-ketoacyl-ACP thioesterase from Solanum habrochaites) in 
E. coli and similar results with heterologous expression SLMKS2 (beta-ketoacyl-ACP 
thioesterase from Solanum lycopersicum). In-vitro assays of purified MKS1 (beta-
ketoacid decarboxylase) by the same authors characterizing the SHMKS2/SLMKS2 
showed significantly higher decarboxylase activity of MKS 1 compared to SHMKS2, 
confirming the hypothesis that SHMKS2/SLMKS2 catalyze the first thioester hydrolysis 
step, and MKS1 catalyzes the second decarboxylation step. The DNA sequences 
encoding the enzymes were codon-optimized to ensure adequate expression in E. coli. 
ACP.SH 0 0 CO o 
H(o ShMKS2 t:.c-{C~OH---M-K_S_1_""'-+' ~-~ 
SIMKS2 3-KetoaCJd Methyl ketone 
Figure 33. The newly introduced methyl ketone synthesis reactions and corresponding enzymes. 
5.2.2. Construction and evaluation of plasmid performance 
Three vectors were used to express the MKSs in E. coli at different levels of 
expression. Plasmid replication and production of heterologous proteins are known to 
place a physiological burden on cells and may even be toxic to the cells at certain levels 
of expression, necessitating the need to evaluate the effect of different levels of 
expression on methyl ketone production in order to determine the optimal balance 
between cell growth and product formation. The pZS vector was chosen for its low-copy 
number of ~5 (pSC101 origin), the pTrcHis2A vector for its moderate copy number of 
~ 15-20 (pBR322 origin), and the pCR2.1 vector for its high copy number of 300-500 
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(pUC origin). Initially, the shmks2 or slmks2 gene catalyzing the first step of the methyl 
ketone synthesis pathway was cloned into the three vectors, as SHMKS2 and SLMKS2 
has exhibited the ability to produce methyl ketones by itself without the aid of MKS 1,21 
the assumption being that ketoacids produced by the enzyme spontaneously 
decarboxylate and/or the enzyme has minor decarboxylation activity at a high enough 
rate for methyl ketone to be produced at a detectable level. The strain background for this 
initial evaluation of plasmid performance was E. coli MG 1655, and cultivations were 
conducted in 10 mL LB-Miller medium at 37°C with appropriate promoter induction 
performed during culture inoculation. Functionality of the pathways expressed under 
these various vectors was evaluated by measuring the concentration of methyl ketones 
produced (extracted through methods outlined in section 3.5). 
Unfortunately, by 12h the strain expressing SHMKS2 on pTrcHis2A (MG1655 
[pTrcHis2A-shmks2]) was the only one producing a detectable amount of methyl 
ketones. The strain carrying pZS-shmks2 grew only slightly better than the producing 
strain but did not produce methyl ketones at a detectable level, which may mean that 
SHMKS2 thioesterase activity may be so low as to require a higher level of expression to 
produce a significant amount. The strain MG1655 [pCR2.1-shmks2] grew extremely 
slowly, taking almost 24h to reach log-phase and even then producing no detectable 
amounts of methyl ketones, pointing to plasmid instability. One possible cause for this is 
that the protein SHMKS2 may be significantly toxic to E. coli at such high levels. 
Physiological burden due to plasmid replication is a less likely cause, as many other 
studies in the literature have used pCR2.1 successfully for overproduction of other 
proteins. All strains expressing SLMKS2 did not produce detectable amounts of methyl 
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ketones, possibly due to hindered activity in vivo in the non-native environment of E. 
coli. Verification of protein expression and identification of products in the producing 
strain will be detailed in the next section. 
With pTrcHis2A-shmks2 being the most functional construct, the gene mks1 was 
cloned in to assemble a single polycistronic operon expressing both shmks2 and mks 1 in 
order to fully introduce the non-native methyl ketone synthesis pathway, yielding the 
plasmid pTrcHis2A-shmks2-mksl. Contrary to expectations, cultivation of the strain 
carrying this plasmid yielded almost no increase in methyl ketone levels over the strain 
expressing only SHMKS2. This implies that the thioester hydrolysis catalyzed by 
SHMKS2 is the rate-limiting step between the two steps of methyl ketone synthesis. 
Another possibility is that the rate of spontaneous decarboxylation far exceeds the 
decarboxylase activity of MKS 1. However unnecessary MKS 1 may seem, the co-
expression of mks 1 did not inhibit growth significantly. These results led to the plasmid 
pTrcHis2A-shmks2-mks1 being chosen as the expression system that conveyed the most 
functional and complete methyl ketone synthesis pathway, and was the primary plasmid 
used in further strain characterization studies. As aforementioned, verification of protein 
expression and identification of products in this strain will be detailed in the next section. 
j 5.2.3. Verification of enzyme expression and identification of products 
! 
Expression of proteins SHMKS2 and MKS 1 were verified by SDS-P AGE gel 
analysis of whole cell extracts. The bands for SHMKS2 and MKS 1 when expressed by 
the pZS vector were unable to be discerned from the background banding, most likely 
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due to low expression. Protein expression was not verified for pCR2.1-shmks2 or 
pCR2.1-shmks2-mkl due to aforementioned plasmid instability issues. 
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Figure 34. SDS-PAGE gel analysis for verification of protein expression. 
"pTH" is short for pTrcHis2A. "pTH-blank" denotes the pTrcHis2A vector as supplied by Invitrogen without any cloned genes. 
Product identification came in two forms: one-dimensional proton NMR and GC-
MS. The following shows the identification of the three methyl ketone products detected 
as produced by MG 1655 [pTrcHis2A-shmks2-mksl]. The extract was derived from a 
sonicated minimal media liquid culture that was obtained 20 hours after inoculation, 
using the established techniques as described previously in section 3.5. 
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Figure 35. GC-MS identification of 3 methyl ketones as produced by MG1655 [pTrcHis2A-shmks2-
mksl] 
Figure 35 shows the mass spectra associated with the methyl ketone labeled under them, 
and an inset chromatogram showing the peak from which the spectra was obtained. The 
calculated concentrations of methyl ketones were in agreement with those calculated 
from the GC-FID. 2-Tridecanone was the major product by a significant margin, 
followed by 2-undecanone, and fmally 2-nonanone. 2-Nonanone was detected by the GC-
MS due to heightened sensitivity of that instrument, but was not ever detected in the GC-
FID. Controls using the blank pTrcHis2A plasmid were also analyzed, and no methyl 
ketones were detected in those samples. 
The NMR results also agree with the GC-MS results, as shown in Figure 36. The 
red boxes indicate where the signature peaks are aligned across the NMR spectra. The Hl 
corresponds to the chemical shift of the protons on the first carbon (methyl next to the 
ketone), the main signature peak of a methyl ketone. The H3 corresponds to the chemical 
shifts of the protons of the third carbon, which again we see in the sample and not in the 
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control. The inset chemical structure shows the extent to which a chemical structure can 
be implied by the peaks surrounded in red (the HI and H3 peaks). Unfortunately, chain 
length of methyl ketones cannot be determined even in pure methyl ketone samples due 
to the overlapping peaks in the aliphatic regions around 1.2-1.3 ppm. 
H1 LM 
..• . .. 
Figure 36. NMR results comparing standard, sample, and control peaks. 
Subsequent product quantifications were done by integration of GC-FID peaks 
after the peak identities were confmned from NMR/GC-MS. 
From the pathway balances, it is known that the conversion of glucose to methyl 
ketones generates excess reducing equivalents, thus requiring the presence of an external 
electron acceptor to achieve redox balance. Though aerobic conditions meet this need, the 
TCA cycle which is active under these conditions compete for acetyl-CoA with the fatty 
82 
acid synthesis cycle, decreasing the yield of methyl ketones from glucose. Microaerobic 
conditions have been previously utilized to achieve redox balance while still maintaining 
the ability to synthesize reduced products at high yields.99 Similarly, it was hypothesized 
that an optimal microaerobic condition exists between aerobic and anaerobic conditions 
which will increase yields of the more-reduced methyl ketones from glucose due to 
inactivation of the competing TCA cycle while still providing enough oxygen for 
oxidative phosphorylation to close the redox balance. 
Using both the MG1655 [pTrcHis2A-shmks2-mks1] and MG1655 [pTrcHis2A-
shmks2] strains that exhibited the highest methyl ketone production thus far, the effect of 
aerobicity was examined roughly by altering shake flask working volume. By increasing 
the working volume, the surface area available for oxygen transfer decreases (due to the 
conical nature of the Erlenmeyer flask), resulting in decreased aerobicity within the 
culture ceteris paribus. Working volumes of 10 mL, 20 mL, and 30 mL were tested in 
125 mL Erlenmeyer flasks. Cultivation was in MOPS minimal media as described in 
section 3.5 supplemented with 10 giL glucose at 37°C for 18h, with pH controlled using 
calcium carbonate. The titers and yields calculated can be seen in Figure 37. 
Though there is not much difference between 30 and 20 mL working volumes, 
there is a slight trend of increased methyl ketone concentration. This can be attributed to 
the decreased growth rates of the cells when moving towards more anaerobic conditions -
in general, rate of product formation can be correlated to specific growth rate. 100 
However, in agreement with the hypothesis, the yield of total methyl ketones from 
glucose slowly increases as aerobicity decreases, inferring that the conversion is more 
efficient as conditions move towards a microaerobic state. The foreseeable disadvantage 
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to moving towards microaerobic conditions is that various fermentative pathways that 
compete with the fatty acid synthesis pathway for carbon become active as conditions 
move towards decreased oxygen availability. This knowledge has guided subsequent 
genetic modifications and a more rigorous control of aerobicity that will be detailed in 
later sections. 
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Figure 37. Effect of aerobicity on methyl ketone titer and yield. 
"UD" denotes 2-undecanone. "TD" denotes 2-tridecanone. "pTH" denotes pTric His2A. Numbers on the x-ax is denote culture working 
volumes. · 
5.4. ENGINEERED STRAINS FOR THE CONVERSION OF GLUCOSE TO METHYL 
KETONES UNDER MICROAEROBIC CONDITIONS 
Moving towards microaerobic conditions has been found to increase yield of 
methyl ketones from glucose under the wild-type strain background. However, under 
anaerobic and microaerobic conditions, E. coli begins to convert glucose into a mixture 
of metabolic products primarily of acetate and formate, with smaller amounts of lactate, 
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succinate, and ethanol.99• 101 These pathways are shown in Figure 38. This is problematic 
as these fermentative pathways consume acetyl-CoA (the building block of fatty acids) 
and pyruvate (precursor to acetyl-CoA), which may ultimately divert carbon away from 
methyl ketones. Thus, it was hypothesized that knocking out some or all of these 
pathways would result in increased yields. 
Phosphoenolpyruvate ! ~ADP PTS PYK (pykF, pykA) ATP 
NAO+ NAOH 
Lactate • :\ 1< Pyruvate 
LDH {ldhA) 
PDH (aceEF,~pdA) F:Fl (pf/8) FHL 
NADH, co2 Formate ----+ C02, H2 (fdhF, 
Acetyi-CoA hycB-1) 
NADH NAD+~H ~to) 
(adhE) 
Acetaldehyde Acetyl phosphate 
NADH ""f ADH ACK r ADP 
NAD+~(adhE) (ackA) ~ ATP 
Ethanol Acetate 
Figure 38. Mixed acid fermentative pathways and knockouts 
The plasmid pTrcHis2A-shmks2-mks1 was transformed into several mutants that 
were constructed for this study, which are listed in Table 6 for convenience. The mutants 
were combinations of the 4 possible pathway knockouts. Cultivation was done in MOPS 
minimal media supplemented with 10 giL glucose as described in section 3.5. Shake 
flasks (125 mL total volume) were prepared with 10, 20, 30, 40, and 75 mL working 
volumes of media, inoculated from starter cultures to 0.05, and incubated for different 
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durations depending on the working volume (18h for 10, 20 mL working volumes, 22h 
for 30, 40, and 75 mL working volumes). Different durations were used due to the 
lowered growth rates as anaerobic conditions were approached. The lowered growth rates 
forced higher incubation durations in order to harvest the cells when less than half the 
glucose remained. 
Table 6. List ofMG1655 mutants constructed 
AadhE 
AldhA 
ApoxB 
A pta 
AadhE Apta 
AldhA ApoxB 
AldhA ApoxB Apta 
AadhE AldhA ApoxB Apta 
The effects of these knockouts and also the effect of aerobicity for each knockout 
combination were evaluated by measuring yield and methyl ketone concentration. 
Comparison with the knockout strains and the wild-type background strain can be done 
by comparing the data in Figure 37 and Figure 38, as the data in Figure 37 was obtained 
through the same cultivation conditions as those used for the 10, 20, and 30 mL working 
volume cultures in Figure 38. The full HPLC profiles (measurement of major acids, 
pyruvate, glucose remaining) and OD/pH values can be viewed in the appendix A. 
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The data shows quite clearly that highest yield and titers are attained through 
strain backgrounds with almost all the fermentative pathways knocked out (~ldhA 
~poxB ~pta and ~adhE ~ldhA ~poxB ~pta) as was hypothesized. Almost all the 
different knockout strains performed slightly better in terms of yield over the wild-type 
background in varying degrees, which was also expected. Curiously, the double-mutant 
~ldhA ~poxB gave low titers and yields compared to its respective single-mutants 
(~ldhA-only and ~poxB-only), with the yield values similar to the non-engineered wild-
type. With growth and glucose consumption similar to the other strains, this was 
unexpected, and HPLC analysis revealed build-up of pyruvate pools much more so than 
in the other mutant strains. This is partially contrary to the hypothesis that knocking out 
the competing pathways for pyruvate, thus increasing pools of pyruvate, would lead to 
increased flux down to acetyl-CoA and ultimately to methyl ketones. However, an 
additional pta deletion relieved this build-up. It is unclear as to why this had occurred, 
though it remains that the quadruple and triple mutants performed the best in terms of 
both concentration and yield, with the former being slightly better in these metrics than 
the latter. This makes sense, as the rationale behind the knockouts was to redirect carbon 
flux from fermentative pathways that became active in the presence of lesser oxygen. As 
other metabolite production is increasingly stopped, it is found that there is at least a 
higher proportion of flux traveling through the fatty acid synthesis pathways, resulting in 
a subsequent higher increase in both methyl ketone yield and concentration. 
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The best performing strain from the shake flask experiments detailed in the 
previous section (section 5.5) was cultivated in a 500 mL bioreactor vessel in which pH 
and dissolved oxygen could be tightly controlled. In order to quantify the specific 
dissolved oxygen (DO) percentage that optimizes yield and titer and to get a better grasp 
on how these metrics change with specific changes in DO, several bioreactor 
fermentations were conducted with different DO setpoints. MOPS minimal media as 
prepared in section 3.5 was supplemented with 20 giL glucose. The pH was set at 7, 
temperature at 37°C, and cultures were harvested at 12h. Figure 40 shows how yield and 
titer change over a range of dissolved oxygen values between 2% and 20%. A table with 
these values, OD, and HPLC data is included in appendix A. 
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Figure 40. Methyl ketone concentration and yield as a function of DO(%) 
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An unexpected outcome was a marked increase in both the concentration and 
yield of methyl ketones over those obtained from shake-flasks. There are several 
parameters that changed when moving from shake-flasks to the bioreactors which may be 
responsible for this drastic improvement of methyl ketone production. The first is more 
consistent oxygen availability. One study, which measured dissolved oxygen content over 
the course of E. coli and yeast fermentations in 250-mL shake-flasks with respect to both 
culture volume and shaker RPM, showed high variability of DO during the 
fermentations. 102 Specifically, the authors encountered the onset of oxygen limitation 
(DO measured at -0%) for both 50 mL and 75 mL culture volumes and at 150, 250, and 
350 RPM shaker speeds. During late exponential and early stationary phase, the dissolved 
oxygen content rapidly increased back to almost 100% saturation. Increases in RPM and 
culture volumes increased the onset and duration of the oxygen-limiting conditions. 
Though these results cannot be perfectly extrapolated to explain the conditions in 125-mL 
shake-flasks with 10 mL cultures, it gives some insight into the conditions of the 30 and 
40 mL cultures due to the similarities of the culture volume to flask volume ratios used in 
the aforementioned study. Conversely, in the bioreactor, DO was monitored and kept 
steady at specified set-points above 0% saturation, while keeping DO at these setpoints 
throughout all phases of growth including late exponential and stationary phases instead 
of allowing it to rise back to high levels of saturation. In other words, the increased 
availability of oxygen in the media, however low the saturation level, may have greatly 
improved the production of methyl ketones. Secondly, in the shake-flasks, there may 
have been losses of methyl ketones through evaporation, as methyl ketones have been 
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detected in the headspace of methyl ketone-producing E. coli. 20 In the bioreactor setup, a 
condenser is placed between the headspace and the headspace outlet to minimize losses 
of volatile compounds to the outside. However, according to studies reporting the vapor 
pressure of various methyl ketones, 2-tridecanone and 2-undecanone are not significantly 
volatile. 103 The vapor pressures of both compounds are under 1 mm Hg at 25°C - in 
comparison, at this temperature, water has a vapor pressure of 23.8 mm Hg, ethanol of 55 
mm Hg, and acetate of 17 mm Hg. Thirdly, it is widely known that there are optimal 
ranges of pH for maximum activity/stability of enzymes. In the shake-flask cultures, even 
when supplemented with calcium carbonate to control pH, the pH would decrease in 
some cases to 5.0-6.0. In the bioreactor, pH was maintained at a constant 7.0 throughout 
cultivation. It may be that the enzymes SHMKS2 and MKS 1 exhibit much higher activity 
at the neutral pH of7, which would explain the rise in MK titer and yield. 
Nevertheless, judging from strain performance by the 12h mark, a maximum for 
yield and concentration is attained when the culture conditions are set at DO 10%. To 
further characterize the strain under these optimal growth conditions, a fermentation was 
run using DO set at 10% and glucose supplemented at 50 giL, with sampling every 6h 
starting from 12h to 48h after inoculation. The results of the time-course experiment is 
show in Figure 41, with growth (OD) and glucose consumption in Figure 42. 
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The data shows methyl ketone titers approaching 450 mg/L by 48 hours, with 
yield leveling off at 17 mg MK I g glucose. Both metrics are the highest recorded for any 
of the strains thus far. Growth entered late exponential to stationary phase by 12 h, at 
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which point the rate of glucose consumption steadily decreased as expected in concert 
with the growth profile. If all the glucose in the media were to have been consumed and 
the yield were to remain constant, the culture would have produced close to 850 mg/L of 
methyl ketones. 
6. CONCLUSION 
Platform chemicals are a handful of compounds which act as precursors for the 
synthesis of thousands of high-volume products we use everyday such as plastics, 
agrochemicals, chemical solvents, etc. Currently, platform chemicals are derived from 
fossil carbon, which is widely regarded as a non-renewable resource. The long-term 
future of the chemical industry is thus predicated on the conversion of a renewable 
resource such as biomass into these platform chemicals, a process which can be 
accomplished through the metabolic engineering of micro-organisms. In this study, E. 
coli was engineered to produce methyl ketones, a highly reduced platform chemical that 
has never been synthesized in E. coli according to existing literature, at almost 450 mg/L 
concentrations. Through establishment of optimal operating conditions, and executing on 
metabolic engineering strategies hypothesized to increase the efficiency of the 
bioconversion under the established optimal conditions, methyl ketone concentrations 
were increased almost 75-fold from confirmatory levels of -6 mg/L to relatively 
significant levels of -450 mg/L. 
In the future, the optimal operating conditions and genetic background arrived at 
in this study could act as a starting point for the engineering of new strains that involve 
grafting other novel pathways that utilize polyketide intermediates. On the other hand, 
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there are many other modifications proposed to increasing flux through the fatty acid 
synthesis pathway that do not involve gene deletion such as over-expression of acetyl-
CoA carboxylase, over-expression of malic enzyme to increase NADPH pools, and a few 
others. These modifications have a high chance of success as they have already been 
published to be viable strategies for increasing fatty acid production. 
The improved understanding of the behavior of the polyketide synthesis pathway 
through evaluation of the effects of various genetic modifications may, in the future, 
coalesce into well-defined and pertinent metabolic engineering strategies that can be 
broadly applied towards the efficient bioconversion of glucose to other targets as shown 
in Figure 43, since they all draw from fatty acid and polyketide metabolism. 
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Figure 43. An array of current and future target molecules that can be derived from polyketide 
metabolism 
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f 7 .1. TRANSPORT OF METHYL KETONES 
The standard lysis and extraction method used to quantify methyl ketones after 
cultivation involved extraction from the culture broth which included the lysed contents 
of the cells. Methyl ketone concentrations in supernatant and sonicated culture broth after 
18h cultivation in MOPS minimal media supplemented with 10 g/L glucose is shown in 
Figure 44. The graph shows clearly that a majority of the methyl ketones remain as 
intracellular metabolites. 
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Figure 44. Methyl ketone production of two strains. 
Note: pTH refers to pTrcHis2A. 
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Based on this data, methyl ketones are not excreted into the extracellular medium. 
The identification of natural transporters of methyl ketones could increase the efficiency 
of the process not only by increasing the ease of extraction by avoiding the need to break 
down cells, but also increase the efficiency of the reaction itself by pushing it towards 
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product formation through Le Chatelier's principle. The methyl ketone transporters are 
currently unknown for both methyl ketone producers as well as pethyl ketone utilizers 104• 
However, there is already a native unspecified transporter that is able to transport methyl 
ketones both into and outside of the cytoplasm, as seen from some studies and the results 
shown in figures 35 and 36. Several other targets for this include fatty acid transporters 
(as methyl ketones are fatty-acid like molecules), specifically the outer membrane protein 
FadL, periplasmic protein Tsp, and the inner membrane protein FadD 105• Another 
possible target is a wild tomato plasma membrane intrinsic protein (GenBank accession 
BI925004), which may be a transporter of methyl ketones 21 • This protein was one of 
those that were singled out through an aforementioned transcriptome analysis of methyl 
ketone-producing plants versus non-producers (the list is shown in Table 2, page 34). It 
was overexpressed 39-fold in plants producing methyl ketones compared to those 
producing little to no methyl ketones. 
Table 7. pH, OD, and HPLC data for knockout strains in shake flask experiments 
~~ "0 0 re:s~ r <e:~ ~)> ~en ~., ~-a J: "' ~@ 'e.r::: 'e.o <e.'< r:::~ 0 r=sr::: 0. .c ... 
.c 8 . .C3 .C2 ~cno ~iii 3 -· r::: 0 "' =s 
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< CD =s 3 en (;" !2. (;" =s (;" !t ~<0 CD CD !t 3 a. co 
.c £; 
ad hE 
knockout 10 5.2 2.16 8.89 0.407 0.000 1.276 0.113 0.184 1.788 
20 7.14 4.4 9.57 0.298 0.000 0.852 0.027 0.118 0.000 
30 5.54 1.7 7.27 0.249 0.000 1.043 0.219 0.212 1.697 
40 5.66 1.24 5.27 0.250 0.000 0.970 0.195 0.287 1.507 
75 5.68 0.66 4.87 - - - - - -
ldhA 
knockout 10 6.31 3.8 9.38 0.399 0.000 0.113 0.062 0.037 0.576 
20 6.57 1.96 7.23 1.078 0.235 0.060 0.183 0.342 0.497 
30 5.02 1.5 6.81 0.595 0.180 0.098 0.206 0.179 0.891 
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40 5.23 1.24 7.05 0.733 0.221 0.055 0.253 0.223 0.991 
75 6.78 1.06 7.03 - - - - - -
poxB 
knockout 10 6.85 4 9.45 0.745 0.000 0.370 0.047 0.000 0.831 
20 6.58 3 6.44 3.021 0.000 0.331 0.078 0.100 0.858 
30 7.02 2.1 5.93 4.479 0.000 0.589 0.153 0.065 0.000 
40 6.94 1.92 6.65 4.764 0.000 0.380 0.193 0.000 0.000 
75 6.75 1.24 5.66 
- - - - - -
pta 
knockout 10 6.31 4.74 5.87 0.032 0.051 2.351 0.075 0.037 0.669 
20 6.57 3.88 7.30 0.000 0.314 2.144 0.087 0.416 2.207 
30 5.02 1.4 5.71 0.000 0.456 3.747 0.279 0.903 0.000 
40 5.23 1.46 5.88 0.000 0.544 3.589 0.591 1.308 0.209 
75 7.02 1.88 8.07 - - - - - -
ad hE/pta 
knockout 10 6.62 2.88 8.73 0.070 0.000 0.681 0.083 0.000 0.213 
20 5.43 2.2 7.39 0.010 0.049 0.967 0.170 0.158 1.586 
30 5.5 1.5 9.31 0.012 0.156 1.047 0.150 0.251 1.752 
40 5.55 1.12 9.46 0.016 0.210 1.027 0.154 0.368 1.677 
75 5.97 0.63 8.98 - - - - - -
ldhA/poxB 
knockout 10 6.96 3.3 9.63 0.042 0.000 0.585 0.064 0.000 0.000 
20 5.46 2.14 9.10 0.000 0.063 0.788 0.170 0.139 1.600 
30 5.32 1.58 7.64 0.020 0.169 1.005 0.167 0.304 2.122 
40 5.5 1.22 9.85 0.013 0.252 0.963 0.179 0.407 2.039 
75 5.69 0.63 8.70 - - - - - -
ldhA/poxB/ 
pta 
knockout 10 6.7 3.24 6.92 0.000 0.000 0.120 0.073 0.000 0.346 
20 5.42 1.7 5.20 0.000 0.000 0.049 0.077 0.030 1.041 
30 5.71 1.52 5.77 0.000 0.000 0.048 0.073 0.040 1.269 
40 5.63 1.08 5.83 0.000 0.000 0.050 0.129 0.066 1.483 
75 5.58 0.87 6.04 
- - - - - -
adhE/IdhA/ 
poxB/pta 
knockout 10 6.7 3.11 6.23 - - - - - -
20 7.25 2.82 4.69 0.056 0.000 0.052 0.071 0.064 0.415 
30 7.07 2.1 6.57 0.033 0.000 0.043 0.153 0.225 1.356 
40 7.09 1.4 6.42 0.000 0.000 0.027 0.096 0.233 0.919 
75 6.88 1 8.00 - - - - - -
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Table 8. Tabulated data for fermentor experiment varying DO from 2 to 20%. 
! 18 i n IN i n IN IIi ~ n ~~ ~~ ~~ 18 I ~1r ~~~ ~g> ~~~ ~~ 0 ' 0 ' 0 -:::> -1 :::> c :::> c: fl n 0 2 0 vo n n> c: 0 :;· ~ ~ 3 ~ n> - ;. ~ ~ 0. i5" i5" -
12 50% 48 2 so - 5.25 - - - - - - - -
12 10% 79.8 5.2 85.00 12.08 7.04 15.51 5.48 0.05 0.00 0.19 0.08 0.08 1.02 
12 5% 46.6 2.96 49.56 9.43 5.25 9.64 5.14 0.00 0.00 0.13 0.18 0.27 1.76 
12 2% 2.54 ND 2.54 1.36 1.86 6.05 0.42 0.00 0.00 0.00 0.04 0.00 0.16 
24 2% 6.19 ND 6.19 2.94 2.10 8.97 0.69 0.00 0.00 0.00 0.03 0.00 0.25 
36 2% 20 ND 20.00 12.43 1.61 3.29 6.08 0.18 0.00 0.24 0.09 0.00 1.06 
48 2% 23 1.92 24.92 18.57 1.34 2.80 8.90 0.07 0.00 0.61 0.11 0.00 3.40 
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